A glucose transport facilitator that is expressed primarily in PANCREATIC BETA CELLS; LIVER; and KIDNEYS. It may function as a GLUCOSE sensor to regulate INSULIN release and glucose HOMEOSTASIS.
A ubiquitously expressed glucose transporter that is important for constitutive, basal GLUCOSE transport. It is predominately expressed in ENDOTHELIAL CELLS and ERYTHROCYTES at the BLOOD-BRAIN BARRIER and is responsible for GLUCOSE entry into the BRAIN.
A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake.
A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES.
A major glucose transporter found in NEURONS.
A hexose transporter that mediates FRUCTOSE transport in SKELETAL MUSCLE and ADIPOCYTES and is responsible for luminal uptake of dietary fructose in the SMALL INTESTINE.
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
A family of vesicular amine transporter proteins that catalyze the transport and storage of CATECHOLAMINES and indolamines into SECRETORY VESICLES.
A neuronal and epithelial type glutamate plasma membrane transporter protein.
A drug formerly used as an antipsychotic and treatment of various movement disorders. Tetrabenazine blocks neurotransmitter uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system.
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).
A family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid GLYCINE. They differ from GLYCINE RECEPTORS, which signal cellular responses to GLYCINE. They are located primarily on the PLASMA MEMBRANE of NEURONS; GLIAL CELLS; EPITHELIAL CELLS; and RED BLOOD CELLS where they remove inhibitory neurotransmitter glycine from the EXTRACELLULAR SPACE.
A family of plasma membrane neurotransmitter transporter proteins that couple the uptake of GLUTAMATE with the import of SODIUM ions and PROTONS and the export of POTASSIUM ions. In the CENTRAL NERVOUS SYSTEM they regulate neurotransmission through synaptic reuptake of the excitatory neurotransmitter glutamate. Outside the central nervous system they function as signal mediators and regulators of glutamate metabolism.
A family of monosaccharide transport proteins characterized by 12 membrane spanning helices. They facilitate passive diffusion of GLUCOSE across the CELL MEMBRANE.
An amino acid intermediate in the metabolism of choline.
The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
A family of POTASSIUM and SODIUM-dependent acidic amino acid transporters that demonstrate a high affinity for GLUTAMIC ACID and ASPARTIC ACID. Several variants of this system are found in neuronal tissue.
Integral membrane proteins of the LIPID BILAYER of SECRETORY VESICLES that catalyze transport and storage of biogenic amine NEUROTRANSMITTERS such as ACETYLCHOLINE; SEROTONIN; MELATONIN; HISTAMINE; and CATECHOLAMINES. The transporters exchange vesicular protons for cytoplasmic neurotransmitters.
2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.
A cytotoxic member of the CYTOCHALASINS.
Glucose in blood.
A non-metabolizable glucose analogue that is not phosphorylated by hexokinase. 3-O-Methylglucose is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems. (J Neurochem 1993;60(4):1498-504)
A family of MEMBRANE TRANSPORT PROTEINS that require ATP hydrolysis for the transport of substrates across membranes. The protein family derives its name from the ATP-binding domain found on the protein.
Methylglucosides are a type of sugar alcohols, specifically methylated glucose derivatives, which are used as sweetening agents, excipients, and solvents in pharmaceutical and cosmetic products due to their low toxicity and good solubility in water.
The founding member of the sodium glucose transport proteins. It is predominately expressed in the INTESTINAL MUCOSA of the SMALL INTESTINE.
The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN.
A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.
Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS.
A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Proteins involved in the transport of organic anions. They play an important role in the elimination of a variety of endogenous substances, xenobiotics and their metabolites from the body.
Phlorhizin is a non-transportable glucose analog that inhibits the sodium-glucose cotransporter 1 (SGLT1) and aldohexose transporter (GLUT2), leading to reduced intestinal absorption and increased renal excretion of glucose, which is used in research to study glucose transport and diabetes-related processes.
An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.
Phloretin is a dihydrochalcone flavonoid, primarily found in apple tree leaves and roots, which exhibits antioxidant properties and has been studied for its potential role in skin care, cancer prevention, and diabetes management, although more research is needed to fully understand its mechanisms and clinical applications.
The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.
A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
Monosaccharide transport proteins that function as active symporters. They utilize SODIUM or HYDROGEN IONS to transport GLUCOSE across CELL MEMBRANES.
Transport proteins that carry specific substances in the blood or across cell membranes.
Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white.
Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals.
The rate dynamics in chemical or physical systems.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
A family of proteins involved in the transport of monocarboxylic acids such as LACTIC ACID and PYRUVIC ACID across cellular membranes.
Membrane transporters that co-transport two or more dissimilar molecules in the same direction across a membrane. Usually the transport of one ion or molecule is against its electrochemical gradient and is "powered" by the movement of another ion or molecule with its electrochemical gradient.
Propylamines are organic compounds consisting of an amino group (-NH2) attached to a propyl group (CH3CH2CH2-), which can act as central nervous system stimulants, local anesthetics, or vasopressors, depending on their specific chemical structure.
An enzyme that catalyzes the conversion of ATP and a D-hexose to ADP and a D-hexose 6-phosphate. D-Glucose, D-mannose, D-fructose, sorbitol, and D-glucosamine can act as acceptors; ITP and dATP can act as donors. The liver isoenzyme has sometimes been called glucokinase. (From Enzyme Nomenclature, 1992) EC 2.7.1.1.
Hexoses are simple monosaccharides, specifically six-carbon sugars, which include glucose, fructose, and galactose, and play crucial roles in biological processes such as energy production and storage, and structural components of cells.
An enzyme of the oxidoreductase class that catalyzes the conversion of beta-D-glucose and oxygen to D-glucono-1,5-lactone and peroxide. It is a flavoprotein, highly specific for beta-D-glucose. The enzyme is produced by Penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. (From Enzyme Nomenclature, 1992) EC 1.1.3.4.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Glycogen is a multibranched polysaccharide of glucose serving as the primary form of energy storage in animals, fungi, and bacteria, stored mainly in liver and muscle tissues. (Two sentences combined as per your request)
Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of serotonergic neurons. They are different than SEROTONIN RECEPTORS, which signal cellular responses to SEROTONIN. They remove SEROTONIN from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. Regulates signal amplitude and duration at serotonergic synapses and is the site of action of the SEROTONIN UPTAKE INHIBITORS.
The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.
A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
A glutamate plasma membrane transporter protein found in ASTROCYTES and in the LIVER.
A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
Organic or inorganic compounds that contain the -N3 group.
A continuous cell line that is a substrain of SWISS 3T3 CELLS developed though clonal isolation. The mouse fibroblast cells undergo an adipose-like conversion as they move to a confluent and contact-inhibited state.
A zinc-containing sialoglycoprotein that is used to study aminopeptidase activity in the pathogenesis of hypertension. EC 3.4.11.3.
Substances which lower blood glucose levels.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed)
Cell lines whose original growing procedure consisted being transferred (T) every 3 days and plated at 300,000 cells per plate (J Cell Biol 17:299-313, 1963). Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION.
Cellular proteins and protein complexes that transport amino acids across biological membranes.
Oligosaccharides containing two monosaccharide units linked by a glycosidic bond.
Established cell cultures that have the potential to propagate indefinitely.
The process of moving proteins from one cellular compartment (including extracellular) to another by various sorting and transport mechanisms such as gated transport, protein translocation, and vesicular transport.
An organic cation transporter found in kidney. It is localized to the basal lateral membrane and is likely to be involved in the renal secretion of organic cations.
A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.
The reversibly oxidized form of ascorbic acid. It is the lactone of 2,3-DIKETOGULONIC ACID and has antiscorbutic activity in man on oral ingestion.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
A glial type glutamate plasma membrane transporter protein found predominately in ASTROCYTES. It is also expressed in HEART and SKELETAL MUSCLE and in the PLACENTA.
The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
'Nerve tissue proteins' are specialized proteins found within the nervous system's biological tissue, including neurofilaments, neuronal cytoskeletal proteins, and neural cell adhesion molecules, which facilitate structural support, intracellular communication, and synaptic connectivity essential for proper neurological function.
A parasitic hemoflagellate of the subgenus Leishmania leishmania that has been found as a natural infection of the Brazilian guinea pig. Its host-tissue relationship is, in general, comparable to that of L. braziliensis.
A group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. (Enzyme Nomenclature, 1992) EC 2.7.1.2.
Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of noradrenergic neurons. They remove NOREPINEPHRINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. It regulates signal amplitude and duration at noradrenergic synapses and is the target of ADRENERGIC UPTAKE INHIBITORS.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN.
A subclass of ORGANIC ANION TRANSPORTERS that do not rely directly or indirectly upon sodium ion gradients for the transport of organic ions.
Membrane proteins whose primary function is to facilitate the transport of positively charged molecules (cations) across a biological membrane.
Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.
A family of proteins involved in the transport of organic cations. They play an important role in the elimination of a variety of endogenous substances, xenobiotics, and their metabolites from the body.
Contractile tissue that produces movement in animals.
A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology.
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.
Proteins involved in the transport of NUCLEOSIDES across cellular membranes.
Abstaining from all food.
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
The commonest and widest ranging species of the clawed "frog" (Xenopus) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals.
A family of plasma membrane neurotransmitter transporter proteins that regulates extracellular levels of the inhibitory neurotransmitter GAMMA-AMINOBUTYRIC ACID. They differ from GABA RECEPTORS, which signal cellular responses to GAMMA-AMINOBUTYRIC ACID. They control GABA reuptake into PRESYNAPTIC TERMINALS in the CENTRAL NERVOUS SYSTEM through high-affinity sodium-dependent transport.
A sodium-glucose transporter that is expressed in the luminal membrane of the PROXIMAL KIDNEY TUBULES.
A glucose dehydrogenase that catalyzes the oxidation of beta-D-glucose to form D-glucono-1,5-lactone, using NAD as well as NADP as a coenzyme.
A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
Amino acid transporter systems capable of transporting neutral amino acids (AMINO ACIDS, NEUTRAL).
Membrane transport proteins that actively co-transport ASCORBIC ACID and sodium ions across the CELL MEMBRANE. Dietary absorption of VITAMIN C is highly dependent upon this class of transporters and a subset of SODIUM GLUCOSE TRANSPORTERS which transport the oxidized form of vitamin C, DEHYDROASCORBIC ACID.
A subclass of ORGANIC ANION TRANSPORTERS whose transport of organic anions is driven either directly or indirectly by a gradient of sodium ions.
The processes whereby the internal environment of an organism tends to remain balanced and stable.
An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed)
Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM).
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
Elements of limited time intervals, contributing to particular results or situations.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.
Components of a cell produced by various separation techniques which, though they disrupt the delicate anatomy of a cell, preserve the structure and physiology of its functioning constituents for biochemical and ultrastructural analysis. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p163)

Time-dependent and tissue-specific effects of circulating glucose on fetal ovine glucose transporters. (1/1042)

To determine the cellular adaptations to fetal hyperglycemia and hypoglycemia, we examined the time-dependent effects on basal (GLUT-1 and GLUT-3) and insulin-responsive (GLUT-4) glucose transporter proteins by quantitative Western blot analysis in fetal ovine insulin-insensitive (brain and liver) and insulin-sensitive (myocardium, skeletal muscle, and adipose) tissues. Maternal glucose infusions causing fetal hyperglycemia resulted in a transient 30% increase in brain GLUT-1 but not GLUT-3 levels and a decline in liver and adipose GLUT-1 and myocardial and skeletal muscle GLUT-1 and GLUT-4 levels compared with gestational age-matched controls. Maternal insulin infusions leading to fetal hypoglycemia caused a decline in brain GLUT-3, an increase in brain GLUT-1, and a subsequent decline in liver GLUT-1, with no significant change in insulin-sensitive myocardium, skeletal muscle, and adipose tissue GLUT-1 or GLUT-4 concentrations, compared with gestational age-matched sham controls. We conclude that fetal glucose transporters are subject to a time-dependent and tissue- and isoform-specific differential regulation in response to altered circulating glucose and/or insulin concentrations. These cellular adaptations in GLUT-1 (and GLUT-3) are geared toward protecting the conceptus from perturbations in substrate availability, and the adaptations in GLUT-4 are geared toward development of fetal insulin resistance.  (+info)

Developmental regulation of genes mediating murine brain glucose uptake. (2/1042)

We examined the molecular mechanisms that mediate the developmental increase in murine whole brain 2-deoxyglucose uptake. Northern and Western blot analyses revealed an age-dependent increase in brain GLUT-1 (endothelial cell and glial) and GLUT-3 (neuronal) membrane-spanning facilitative glucose transporter mRNA and protein concentrations. Nuclear run-on experiments revealed that these developmental changes in GLUT-1 and -3 were regulated posttranscriptionally. In contrast, the mRNA and protein levels of the mitochondrially bound glucose phosphorylating hexokinase I enzyme were unaltered. However, hexokinase I enzyme activity increased in an age-dependent manner suggestive of a posttranslational modification that is necessary for enzymatic activation. Together, the postnatal increase in GLUT-1 and -3 concentrations and hexokinase I enzymatic activity led to a parallel increase in murine brain 2-deoxyglucose uptake. Whereas the molecular mechanisms regulating the increase in the three different gene products may vary, the age-dependent increase of all three constituents appears essential for meeting the increasing demand of the maturing brain to fuel the processes of cellular growth, differentiation, and neurotransmission.  (+info)

High concentration of glucose decreases glucose transporter-1 expression in mouse placenta in vitro and in vivo. (3/1042)

Facilitative glucose transporter-1 (GLUT1) is expressed abundantly and has an important role in glucose transfer in placentas. However, little is known about the regulation of GLUT1 expression in placental cells. We studied the changes in placental GLUT1 levels in relation to changes in glucose concentration in vitro and in vivo. In in vitro experiments, dispersed mouse placental cells were incubated under control (5.5 mM) and moderately high (22 mM) glucose concentrations, and 2-deoxyglucose uptake into cells was studied on days 1-5 of culture. After 4 days of incubation under both conditions, GLUT1 mRNA and proten levels were examined by Northern and immunoblot analyses. Treatment of cells with 22 mM glucose resulted in a significant decrease in 2-deoxyglucose uptake compared with control, from day 2 to day 5 of culture. Moreover, GLUT1 mRNA and protein levels on day 4 of culture were significantly reduced in cells incubated with 22 mM glucose compared with control. Next, we rendered mice diabetic by administering 200 micrograms/g body weight streptozotocin (STZ) on day 8 of pregnancy. Animals were killed on day 12 of pregnancy and placental tissues were obtained. [3H]Cytochalasin B binding study was carried out to assess total GLUTs, and GLUT1 mRNA and protein were measured as above. [3H]Cytochalasin B binding sites in placentas from STZ-treated mice were significantly less than those in control mice. Northern and immunoblot analyses revealed a significant decrease in GLUT1 mRNA and protein levels in diabetic mice compared with the controls. These findings suggest that the glucose concentration may regulate the expression of placental GLUT1.  (+info)

Transcriptional activation of the glucose transporter GLUT1 in ventricular cardiac myocytes by hypertrophic agonists. (4/1042)

Myocardial hypertrophy is associated with increased basal glucose metabolism. Basal glucose transport into cardiac myocytes is mediated by the GLUT1 isoform of glucose transporters, whereas the GLUT4 isoform is responsible for regulatable glucose transport. Treatment of neonatal cardiac myocytes with the hypertrophic agonist 12-O-tetradecanoylphorbol-13-acetate or phenylephrine increased expression of Glut1 mRNA relative to Glut4 mRNA. To study the transcriptional regulation of GLUT1 expression, myocytes were transfected with luciferase reporter constructs under the control of the Glut1 promoter. Stimulation of the cells with 12-O-tetradecanoylphorbol-13-acetate or phenylephrine induced transcription from the Glut1 promoter, which was inhibited by cotransfection with the mitogen-activated protein kinase phosphatases CL100 and MKP-3. Cotransfection of the myocytes with constitutively active versions of Ras and MEK1 or an estrogen-inducible version of Raf1 also stimulated transcription from the Glut1 promoter. Hypertrophic induction of the Glut1 promoter was also partially sensitive to inhibition of the phosphatidylinositol 3-kinase pathway and was strongly inhibited by cotransfection with dominant-negative Ras. Thus, Ras activation and pathways downstream of Ras mediate induction of the Glut1 promoter during myocardial hypertrophy.  (+info)

An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. (5/1042)

The precise mechanisms underlying insulin-stimulated glucose transport still require investigation. Here we assessed the effect of SB203580, an inhibitor of the p38 MAP kinase family, on insulin-stimulated glucose transport in 3T3-L1 adipocytes and L6 myotubes. We found that SB203580, but not its inactive analogue (SB202474), prevented insulin-stimulated glucose transport in both cell types with an IC50 similar to that for inhibition of p38 MAP kinase (0.6 microM). Basal glucose uptake was not affected. Moreover, SB203580 added only during the transport assay did not inhibit basal or insulin-stimulated transport. SB203580 did not inhibit insulin-stimulated translocation of the glucose transporters GLUT1 or GLUT4 in 3T3-L1 adipocytes as assessed by immunoblotting of subcellular fractions or by immunofluorescence of membrane lawns. L6 muscle cells expressing GLUT4 tagged on an extracellular domain with a Myc epitope (GLUT4myc) were used to assess the functional insertion of GLUT4 into the plasma membrane. SB203580 did not affect the insulin-induced gain in GLUT4myc exposure at the cell surface but largely reduced the stimulation of glucose uptake. SB203580 had no effect on insulin-dependent insulin receptor substrate-1 phosphorylation, association of the p85 subunit of phosphatidylinositol 3-kinase with insulin receptor substrate-1, nor on phosphatidylinositol 3-kinase, Akt1, Akt2, or Akt3 activities in 3T3-L1 adipocytes. In conclusion, in the presence of SB203580, insulin caused normal translocation and cell surface membrane insertion of glucose transporters without stimulating glucose transport. We propose that insulin stimulates two independent signals contributing to stimulation of glucose transport: phosphatidylinositol 3-kinase leads to glucose transporter translocation and a pathway involving p38 MAP kinase leads to activation of the recruited glucose transporter at the membrane.  (+info)

Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM. (6/1042)

Animal insulinoma cell lines are widely used to study physiological and pathophysiological mechanisms involved in glucose metabolism and to establish in vitro models for studies on beta-cells. In contrast, human insulinoma cell lines are rarely used because of difficulties in obtaining and culturing them for long periods. The aim of our study was to investigate, under different experimental conditions, the capacity of the human insulinoma cell line CM to retain beta-cell function, particularly the expression of constitutive beta-cell genes (insulin, the glucose transporters GLUT1 and GLUT2, glucokinase), intracellular and secreted insulin, beta-cell granules, and cAMP content. Results showed that CM cells from an early-passage express specific beta-cell genes in response to glucose stimulation, in particular the insulin and GLUT genes. Such capacity is lost at later passages when cells are cultured at standard glucose concentrations. However, if cultured at lower glucose concentration (0.8 mM) for a longer time, CM cells re-acquire the capacity to respond to glucose stimulation, as shown by the increased expression of beta-cell genes (insulin, GLUT2, glucokinase). Nonetheless, insulin secretion could not be restored under such experimental conditions despite the presence of intracellular insulin, although cAMP response to a potent activator of adenylate cyclase, forskolin, was present indicating a viable system. In conclusion, these data show that the human insulinoma cell line CM, at both early-passage and late-passage, posseses a functional glucose-signalling pathway and insulin mRNA expression similar to normal beta-cells, representing, therefore, a good model for studies concerning the signalling and expression of beta-cells. Furthermore, we have previously shown that it is also a good model for immunological studies. In this respect it is important to note that the CM cell line is one of the very few existing human beta-cell lines in long-term culture.  (+info)

Transmembrane segment 5 of the Glut1 glucose transporter is an amphipathic helix that forms part of the sugar permeation pathway. (7/1042)

Transmembrane segment 5 of the Glut1 glucose transporter has been proposed to form an amphipathic transmembrane helix that lines the substrate translocation pathway (Mueckler, M., Caruso, C., Baldwin, S. A., Panico, M., Blench, I., Morris, H. R., Allard, W. J., Lienhard, G. E., and Lodish, H. F. (1985) Science 229, 941-945). This hypothesis was tested using cysteine-scanning mutagenesis in conjunction with the membrane-impermeant, sulfhydryl-specific reagent, p-chloromercuribenzenesulfonate (pCMBS). A series of 21 mutants was created from a fully functional, cysteine-less, parental Glut1 molecule by changing each residue within putative transmembrane segment 5 to cysteine. Each mutant was then expressed in Xenopus oocytes and its steady-state protein level, 2-deoxyglucose uptake activity, and sensitivity to pCMBS were measured. All 21 mutants exhibited measurable transport activity, although several of the mutants exhibited reduced activity due to a corresponding reduction in steady-state protein. Six of the amino acid side chains within transmembrane segment 5 were clearly accessible to pCMBS in the external medium, as determined by inhibition of transport activity, and a 7th residue showed inhibition that lacked statistical significance because of the extremely low transport activity of the corresponding mutant. All 7 of these residues were clustered along one face of a putative alpha-helix, proximal to the exoplasmic surface of the plasma membrane. These results comprise the first experimental evidence for the existence of an amphipathic transmembrane alpha-helix in a glucose transporter molecule and strongly suggest that transmembrane segment 5 of Glut1 forms part of the sugar permeation pathway.  (+info)

Protein interactions with the glucose transporter binding protein GLUT1CBP that provide a link between GLUT1 and the cytoskeleton. (8/1042)

Subcellular targeting and the activity of facilitative glucose transporters are likely to be regulated by interactions with cellular proteins. This report describes the identification and characterization of a protein, GLUT1 C-terminal binding protein (GLUT1CBP), that binds via a PDZ domain to the C terminus of GLUT1. The interaction requires the C-terminal four amino acids of GLUT1 and is isoform specific because GLUT1CBP does not interact with the C terminus of GLUT3 or GLUT4. Most rat tissues examined contain both GLUT1CBP and GLUT1 mRNA, whereas only small intestine lacked detectable GLUT1CBP protein. GLUT1CBP is also expressed in primary cultures of neurons and astrocytes, as well as in Chinese hamster ovary, 3T3-L1, Madin-Darby canine kidney, Caco-2, and pheochromocytoma-12 cell lines. GLUT1CBP is able to bind to native GLUT1 extracted from cell membranes, self-associate, or interact with the cytoskeletal proteins myosin VI, alpha-actinin-1, and the kinesin superfamily protein KIF-1B. The presence of a PDZ domain places GLUT1CBP among a growing family of structural and regulatory proteins, many of which are localized to areas of membrane specialization. This and its ability to interact with GLUT1 and cytoskeletal proteins implicate GLUT1CBP in cellular mechanisms for targeting GLUT1 to specific subcellular sites either by tethering the transporter to cytoskeletal motor proteins or by anchoring the transporter to the actin cytoskeleton.  (+info)

Glucose Transporter Type 2 (GLUT2) is a protein responsible for the facilitated diffusion of glucose across the cell membrane. It is a member of the solute carrier family 2 (SLC2), also known as the facilitative glucose transporter family. GLUT2 is primarily expressed in the liver, kidney, and intestines, where it plays a crucial role in regulating glucose homeostasis.

In the pancreas, GLUT2 is found in the beta cells of the islets of Langerhans, where it facilitates the uptake of glucose from the bloodstream into the cells. Once inside the cell, glucose is metabolized, leading to an increase in ATP levels and the closure of ATP-sensitive potassium channels. This results in the depolarization of the cell membrane and the subsequent opening of voltage-gated calcium channels, allowing for the release of insulin from secretory vesicles into the bloodstream.

In the intestines, GLUT2 is expressed in the enterocytes of the small intestine, where it facilitates the absorption of glucose and other monosaccharides from the lumen into the bloodstream. In the kidneys, GLUT2 is found in the proximal tubules, where it plays a role in reabsorbing glucose from the filtrate back into the bloodstream.

Mutations in the gene that encodes GLUT2 (SLC2A2) can lead to several genetic disorders, including Fanconi-Bickel syndrome, which is characterized by impaired glucose and galactose absorption in the intestines, hepatic glycogen accumulation, and renal tubular dysfunction.

Glucose Transporter Type 1 (GLUT1) is a specific type of protein called a glucose transporter, which is responsible for facilitating the transport of glucose across the blood-brain barrier and into the brain cells. It is encoded by the SLC2A1 gene and is primarily found in the endothelial cells of the blood-brain barrier, as well as in other tissues such as the erythrocytes (red blood cells), placenta, and kidney.

GLUT1 plays a critical role in maintaining normal glucose levels in the brain, as it is the main mechanism for glucose uptake into the brain. Disorders of GLUT1 can lead to impaired glucose transport, which can result in neurological symptoms such as seizures, developmental delay, and movement disorders. These disorders are known as GLUT1 deficiency syndromes.

Glucose Transporter Type 4 (GLUT4) is a type of glucose transporter protein that plays a crucial role in regulating insulin-mediated glucose uptake into cells, particularly in muscle and fat tissues. GLUT4 is primarily located in intracellular vesicles within these cell types and moves to the plasma membrane upon stimulation by insulin or muscle contraction, facilitating the influx of glucose into the cell. Dysfunction in GLUT4 regulation has been implicated in various metabolic disorders, including type 2 diabetes and insulin resistance.

Monosaccharide transport proteins are a type of membrane transport protein that facilitate the passive or active transport of monosaccharides, such as glucose, fructose, and galactose, across cell membranes. These proteins play a crucial role in the absorption, distribution, and metabolism of carbohydrates in the body.

There are two main types of monosaccharide transport proteins: facilitated diffusion transporters and active transporters. Facilitated diffusion transporters, also known as glucose transporters (GLUTs), passively transport monosaccharides down their concentration gradient without the need for energy. In contrast, active transporters, such as the sodium-glucose cotransporter (SGLT), use energy in the form of ATP to actively transport monosaccharides against their concentration gradient.

Monosaccharide transport proteins are found in various tissues throughout the body, including the intestines, kidneys, liver, and brain. They play a critical role in maintaining glucose homeostasis by regulating the uptake and release of glucose into and out of cells. Dysfunction of these transporters has been implicated in several diseases, such as diabetes, cancer, and neurological disorders.

Glucose Transporter Type 3 (GLUT3) is defined in medical terms as a specific type of glucose transporter protein, also known as solute carrier family 2, member 1 (SLC2A1). It is primarily found in the membranes of neurons and plays a crucial role in facilitating the transport of glucose from the extracellular space into the intracellular compartment of these cells. GLUT3 is notable for its high affinity for glucose, allowing it to effectively transport this essential energy source even under conditions of low glucose concentration. Its presence in neurons is particularly important, as these cells have a high demand for glucose to support their metabolic needs and maintain proper function.

Glucose Transporter Type 5 (GLUT5) is a specific type of glucose transporter protein that facilitates the transport of fructose across biological membranes. It is a member of the solute carrier 2 family, also known as SLC2A5. GLUT5 is primarily expressed in the small intestine, where it absorbs dietary fructose from the lumen into the enterocytes, and in the kidney, where it reabsorbs fructose from the glomerular filtrate back into the bloodstream.

Unlike other GLUT family members that transport glucose using a facilitated diffusion mechanism, GLUT5 is unique because it transports fructose via a similar mechanism but with higher affinity and specificity for fructose. The gene encoding GLUT5 is located on chromosome 1 (1p34.2-p36.1) and consists of nine exons and eight introns.

Mutations in the GLUT5 gene have been associated with essential fructosuria, a rare autosomal recessive disorder characterized by an inability to metabolize fructose due to deficient intestinal absorption and renal reabsorption of fructose. However, this condition is benign and does not cause any significant health problems.

Glucose is a simple monosaccharide (or single sugar) that serves as the primary source of energy for living organisms. It's a fundamental molecule in biology, often referred to as "dextrose" or "grape sugar." Glucose has the molecular formula C6H12O6 and is vital to the functioning of cells, especially those in the brain and nervous system.

In the body, glucose is derived from the digestion of carbohydrates in food, and it's transported around the body via the bloodstream to cells where it can be used for energy. Cells convert glucose into a usable form through a process called cellular respiration, which involves a series of metabolic reactions that generate adenosine triphosphate (ATP)—the main currency of energy in cells.

Glucose is also stored in the liver and muscles as glycogen, a polysaccharide (multiple sugar) that can be broken down back into glucose when needed for energy between meals or during physical activity. Maintaining appropriate blood glucose levels is crucial for overall health, and imbalances can lead to conditions such as diabetes mellitus.

Vesicular Monoamine Transporter Proteins (VMATs) are a type of transmembrane protein that play a crucial role in the packaging and transport of monoamines, such as serotonin, dopamine, and norepinephrine, into synaptic vesicles within neurons. There are two main isoforms of VMATs, VMAT1 and VMAT2, which differ in their distribution and function.

VMAT1 (also known as SLC18A1) is primarily found in neuroendocrine cells and is responsible for transporting monoamines into large dense-core vesicles. VMAT2 (also known as SLC18A2), on the other hand, is mainly expressed in presynaptic neurons and is involved in the transport of monoamines into small synaptic vesicles.

Both VMAT1 and VMAT2 are integral membrane proteins that utilize a proton gradient to drive the uptake of monoamines against their concentration gradient, allowing for their storage and subsequent release during neurotransmission. Dysregulation of VMAT function has been implicated in several neurological and psychiatric disorders, including Parkinson's disease and depression.

Excitatory Amino Acid Transporter 3 (EAAT3) is a type of glutamate transporter protein, which is responsible for removing the excitatory neurotransmitter glutamate from the synaptic cleft in the central nervous system. EAAT3 is primarily located on the plasma membrane of neurons and to some extent on astrocytes. It plays a crucial role in maintaining proper glutamate concentration levels in the extracellular space, preventing excitotoxicity and ensuring normal neurotransmission. Mutations in the gene that encodes EAAT3 (SLC1A1) have been associated with neurological disorders such as episodic ataxia, amyotrophic lateral sclerosis, and mood disorders.

Tetrabenazine is a prescription medication used to treat conditions associated with abnormal involuntary movements, such as chorea in Huntington's disease. It works by depleting the neurotransmitter dopamine in the brain, which helps to reduce the severity and frequency of these movements.

Here is the medical definition:

Tetrabenazine is a selective monoamine-depleting agent, with preferential uptake by dopamine neurons. It is used in the treatment of chorea associated with Huntington's disease. Tetrabenazine inhibits vesicular monoamine transporter 2 (VMAT2), leading to depletion of presynaptic dopamine and subsequent reduction in post-synaptic dopamine receptor activation. This mechanism of action is thought to underlie its therapeutic effect in reducing chorea severity and frequency.

(Definitions provided by Stedman's Medical Dictionary and American Society of Health-System Pharmacists)

Insulin is a hormone produced by the beta cells of the pancreatic islets, primarily in response to elevated levels of glucose in the circulating blood. It plays a crucial role in regulating blood glucose levels and facilitating the uptake and utilization of glucose by peripheral tissues, such as muscle and adipose tissue, for energy production and storage. Insulin also inhibits glucose production in the liver and promotes the storage of excess glucose as glycogen or triglycerides.

Deficiency in insulin secretion or action leads to impaired glucose regulation and can result in conditions such as diabetes mellitus, characterized by chronic hyperglycemia and associated complications. Exogenous insulin is used as a replacement therapy in individuals with diabetes to help manage their blood glucose levels and prevent long-term complications.

Glycine is an important amino acid that plays a role in various physiological processes in the human body. Plasma membrane transport proteins are specialized molecules found in the cell membrane that facilitate the movement of specific molecules, such as ions or neurotransmitters like glycine, into and out of cells.

Glycine plasma membrane transport proteins specifically regulate the transcellular movement of glycine across the plasma membrane. These transport proteins belong to a family of solute carriers (SLC) known as the glycine transporters (GlyTs). There are two main isoforms, GlyT1 and GlyT2, which differ in their distribution, function, and regulation.

GlyT1 is widely expressed throughout the central nervous system and plays a crucial role in terminating glycinergic neurotransmission by rapidly removing glycine from the synaptic cleft. This isoform is also involved in regulating extracellular glycine concentrations in various tissues, including the brainstem, spinal cord, and retina.

GlyT2, on the other hand, is primarily localized to presynaptic terminals of glycinergic neurons, where it functions as a vesicular glycine transporter (VGT). Its primary role is to transport glycine into synaptic vesicles for subsequent release into the synapse during neurotransmission.

Dysfunction in glycine plasma membrane transport proteins has been implicated in several neurological disorders, such as hyperekplexia (startle disease) and certain forms of epilepsy. In these cases, impaired glycinergic neurotransmission can lead to motor and cognitive deficits, highlighting the importance of proper glycine transport protein function for normal physiological processes.

Glutamate plasma membrane transport proteins, also known as excitatory amino acid transporters (EAATs), are a type of membrane protein responsible for the uptake of glutamate from the extracellular space into neurons and glial cells in the central nervous system. These transporters play a crucial role in maintaining appropriate levels of glutamate, an important neurotransmitter, in the synaptic cleft to prevent excitotoxicity and ensure normal neurotransmission. There are five subtypes of EAATs (EAAT1-EAAT5) identified in mammals, each with distinct expression patterns and functions.

Glucose Transporter Proteins, Facilitative (GLUTs) are a group of membrane proteins that facilitate the passive transport of glucose and other simple sugars across the cell membrane. They are also known as solute carrier family 2 (SLC2A) members. These proteins play a crucial role in maintaining glucose homeostasis within the body by regulating the uptake of glucose into cells. Unlike active transport, facilitative diffusion does not require energy and occurs down its concentration gradient. Different GLUT isoforms have varying tissue distributions and substrate specificities, allowing them to respond to different physiological needs. For example, GLUT1 is widely expressed and is responsible for basal glucose uptake in most tissues, while GLUT4 is primarily found in insulin-sensitive tissues such as muscle and adipose tissue, where it mediates the increased glucose uptake in response to insulin signaling.

Sarcosine is not a medical condition or disease, but rather it is an organic compound that is classified as a natural amino acid. It is a metabolite that can be found in the human body, and it is involved in various biochemical processes. Specifically, sarcosine is formed from the conversion of the amino acid glycine by the enzyme glycine sarcosine N-methyltransferase (GSMT) and is then converted to glycine betaine (also known as trimethylglycine) by the enzyme betaine-homocysteine S-methyltransferase (BHMT).

Abnormal levels of sarcosine have been found in various disease states, including cancer. Some studies have suggested that high levels of sarcosine in urine or prostate tissue may be associated with an increased risk of developing prostate cancer or a more aggressive form of the disease. However, more research is needed to confirm these findings and establish the clinical significance of sarcosine as a biomarker for cancer or other diseases.

Biological transport refers to the movement of molecules, ions, or solutes across biological membranes or through cells in living organisms. This process is essential for maintaining homeostasis, regulating cellular functions, and enabling communication between cells. There are two main types of biological transport: passive transport and active transport.

Passive transport does not require the input of energy and includes:

1. Diffusion: The random movement of molecules from an area of high concentration to an area of low concentration until equilibrium is reached.
2. Osmosis: The diffusion of solvent molecules (usually water) across a semi-permeable membrane from an area of lower solute concentration to an area of higher solute concentration.
3. Facilitated diffusion: The assisted passage of polar or charged substances through protein channels or carriers in the cell membrane, which increases the rate of diffusion without consuming energy.

Active transport requires the input of energy (in the form of ATP) and includes:

1. Primary active transport: The direct use of ATP to move molecules against their concentration gradient, often driven by specific transport proteins called pumps.
2. Secondary active transport: The coupling of the movement of one substance down its electrochemical gradient with the uphill transport of another substance, mediated by a shared transport protein. This process is also known as co-transport or counter-transport.

I am not aware of a medical definition for an "amino acid transport system X-AG" as it is not a widely recognized or established term in the field of medicine or biology. It is possible that you may have misspelled or mistyped the name, as there are several known amino acid transporters labeled with different letters and numbers (e.g., Systems A, ASC, L, y+L).

If you meant to inquire about a specific amino acid transport system or a particular research study related to it, please provide more context or clarify the term so I can give you an accurate and helpful response.

Vesicular biogenic amine transport proteins (VMATs) are a type of transmembrane protein that play a crucial role in the packaging and transport of biogenic amines, such as serotonin, dopamine, norepinephrine, and histamine, into synaptic vesicles within neurons. These proteins are located on the membranes of neurosecretory vesicles and function to regulate the concentration of these neurotransmitters in the cytoplasm and maintain their storage in vesicles until they are released into the synapse during neurotransmission. VMATs are members of the solute carrier family 18 (SLC18) and consist of two isoforms, VMAT1 and VMAT2, which differ in their distribution and substrate specificity. VMAT1 is primarily found in non-neuronal cells, such as endocrine and neuroendocrine cells, while VMAT2 is predominantly expressed in neurons. Dysregulation of VMATs has been implicated in several neurological and psychiatric disorders, including Parkinson's disease, depression, and attention deficit hyperactivity disorder (ADHD).

Deoxyglucose is a glucose molecule that has had one oxygen atom removed, resulting in the absence of a hydroxyl group (-OH) at the 2' position of the carbon chain. It is used in research and medical settings as a metabolic tracer to study glucose uptake and metabolism in cells and organisms.

Deoxyglucose can be taken up by cells through glucose transporters, but it cannot be further metabolized by glycolysis or other glucose-utilizing pathways. This leads to the accumulation of deoxyglucose within the cell, which can interfere with normal cellular processes and cause toxicity in high concentrations.

In medical research, deoxyglucose is sometimes labeled with radioactive isotopes such as carbon-14 or fluorine-18 to create radiolabeled deoxyglucose (FDG), which can be used in positron emission tomography (PET) scans to visualize and measure glucose uptake in tissues. This technique is commonly used in cancer imaging, as tumors often have increased glucose metabolism compared to normal tissue.

Cytochalasin B is a fungal metabolite that inhibits actin polymerization in cells, which can disrupt the cytoskeleton and affect various cellular processes such as cell division and motility. It is often used in research to study actin dynamics and cell shape.

Blood glucose, also known as blood sugar, is the concentration of glucose in the blood. Glucose is a simple sugar that serves as the main source of energy for the body's cells. It is carried to each cell through the bloodstream and is absorbed into the cells with the help of insulin, a hormone produced by the pancreas.

The normal range for blood glucose levels in humans is typically between 70 and 130 milligrams per deciliter (mg/dL) when fasting, and less than 180 mg/dL after meals. Levels that are consistently higher than this may indicate diabetes or other metabolic disorders.

Blood glucose levels can be measured through a variety of methods, including fingerstick blood tests, continuous glucose monitoring systems, and laboratory tests. Regular monitoring of blood glucose levels is important for people with diabetes to help manage their condition and prevent complications.

3-O-Methylglucose is a form of glucose that has a methyl group (-CH3) attached to the third hydroxyl group (-OH) on the glucose molecule. It is a non-metabolizable sugar analog, which means it cannot be broken down and used for energy by the body's cells.

This compound is sometimes used in scientific research as a marker to study the absorption and transport of glucose in the body. Since 3-O-Methylglucose is not metabolized, it can be detected and measured in various tissues and fluids after it has been absorbed, allowing researchers to track its movement through the body.

It's important to note that 3-O-Methylglucose should not be confused with 3-O-Methyldopa, which is a medication used to treat high blood pressure.

ATP-binding cassette (ABC) transporters are a family of membrane proteins that utilize the energy from ATP hydrolysis to transport various substrates across extra- and intracellular membranes. These transporters play crucial roles in several biological processes, including detoxification, drug resistance, nutrient uptake, and regulation of cellular cholesterol homeostasis.

The structure of ABC transporters consists of two nucleotide-binding domains (NBDs) that bind and hydrolyze ATP, and two transmembrane domains (TMDs) that form the substrate-translocation pathway. The NBDs are typically located adjacent to each other in the cytoplasm, while the TMDs can be either integral membrane domains or separate structures associated with the membrane.

The human genome encodes 48 distinct ABC transporters, which are classified into seven subfamilies (ABCA-ABCG) based on their sequence similarity and domain organization. Some well-known examples of ABC transporters include P-glycoprotein (ABCB1), multidrug resistance protein 1 (ABCC1), and breast cancer resistance protein (ABCG2).

Dysregulation or mutations in ABC transporters have been implicated in various diseases, such as cystic fibrosis, neurological disorders, and cancer. In cancer, overexpression of certain ABC transporters can contribute to drug resistance by actively effluxing chemotherapeutic agents from cancer cells, making them less susceptible to treatment.

Methylglucosides are not a medical term, but rather a chemical term referring to a type of compound known as glycosides, where a methanol molecule is linked to a glucose molecule. They do not have a specific medical relevance, but they can be used in various industrial and laboratory applications, including as sweetening agents or intermediates in chemical reactions.

However, if you meant "Methylglucamine," it is a related term that has medical significance. Methylglucamine is an organic compound used as an excipient (an inactive substance that serves as a vehicle or medium for a drug) in some pharmaceutical formulations. It is often used as a solubilizing agent to improve the solubility and absorption of certain drugs, particularly those that are poorly soluble in water. Methylglucamine is generally considered safe and non-toxic, although it can cause gastrointestinal symptoms such as diarrhea or nausea in some individuals if taken in large amounts.

Sodium-Glucose Transporter 1 (SGLT1) is a protein found in the membrane of intestinal and kidney cells. It is responsible for the active transport of glucose and sodium ions from the lumen into the epithelial cells. In the intestine, SGLT1 plays a crucial role in glucose absorption after meals, while in the kidneys, it helps reabsorb glucose back into the bloodstream to prevent wasting through urine. The transport process is driven by the sodium gradient created by Na+/K+ ATPase, which actively pumps sodium ions out of the cell. SGLT1 inhibitors are used in the treatment of type 2 diabetes to reduce glucose reabsorption and enhance urinary glucose excretion, leading to better glycemic control.

Muscle proteins are a type of protein that are found in muscle tissue and are responsible for providing structure, strength, and functionality to muscles. The two major types of muscle proteins are:

1. Contractile proteins: These include actin and myosin, which are responsible for the contraction and relaxation of muscles. They work together to cause muscle movement by sliding along each other and shortening the muscle fibers.
2. Structural proteins: These include titin, nebulin, and desmin, which provide structural support and stability to muscle fibers. Titin is the largest protein in the human body and acts as a molecular spring that helps maintain the integrity of the sarcomere (the basic unit of muscle contraction). Nebulin helps regulate the length of the sarcomere, while desmin forms a network of filaments that connects adjacent muscle fibers together.

Overall, muscle proteins play a critical role in maintaining muscle health and function, and their dysregulation can lead to various muscle-related disorders such as muscular dystrophy, myopathies, and sarcopenia.

Glutamic acid is an alpha-amino acid, which is one of the 20 standard amino acids in the genetic code. The systematic name for this amino acid is (2S)-2-Aminopentanedioic acid. Its chemical formula is HO2CCH(NH2)CH2CH2CO2H.

Glutamic acid is a crucial excitatory neurotransmitter in the human brain, and it plays an essential role in learning and memory. It's also involved in the metabolism of sugars and amino acids, the synthesis of proteins, and the removal of waste nitrogen from the body.

Glutamic acid can be found in various foods such as meat, fish, beans, eggs, dairy products, and vegetables. In the human body, glutamic acid can be converted into gamma-aminobutyric acid (GABA), another important neurotransmitter that has a calming effect on the nervous system.

Membrane transport proteins are specialized biological molecules, specifically integral membrane proteins, that facilitate the movement of various substances across the lipid bilayer of cell membranes. They are responsible for the selective and regulated transport of ions, sugars, amino acids, nucleotides, and other molecules into and out of cells, as well as within different cellular compartments. These proteins can be categorized into two main types: channels and carriers (or pumps). Channels provide a passive transport mechanism, allowing ions or small molecules to move down their electrochemical gradient, while carriers actively transport substances against their concentration gradient, requiring energy usually in the form of ATP. Membrane transport proteins play a crucial role in maintaining cell homeostasis, signaling processes, and many other physiological functions.

A Glucose Tolerance Test (GTT) is a medical test used to diagnose prediabetes, type 2 diabetes, and gestational diabetes. It measures how well your body is able to process glucose, which is a type of sugar.

During the test, you will be asked to fast (not eat or drink anything except water) for at least eight hours before the test. Then, a healthcare professional will take a blood sample to measure your fasting blood sugar level. After that, you will be given a sugary drink containing a specific amount of glucose. Your blood sugar levels will be measured again after two hours and sometimes also after one hour.

The results of the test will indicate how well your body is able to process the glucose and whether you have normal, impaired, or diabetic glucose tolerance. If your blood sugar levels are higher than normal but not high enough to be diagnosed with diabetes, you may have prediabetes, which means that you are at increased risk of developing type 2 diabetes in the future.

It is important to note that a Glucose Tolerance Test should be performed under the supervision of a healthcare professional, as high blood sugar levels can be dangerous if not properly managed.

Isoflurane is a volatile halogenated ether used for induction and maintenance of general anesthesia. It is a colorless liquid with a pungent, sweet odor. Isoflurane is an agonist at the gamma-aminobutyric acid type A (GABAA) receptor and inhibits excitatory neurotransmission in the brain, leading to unconsciousness and immobility. It has a rapid onset and offset of action due to its low blood solubility, allowing for quick adjustments in anesthetic depth during surgery. Isoflurane is also known for its bronchodilator effects, making it useful in patients with reactive airway disease. However, it can cause dose-dependent decreases in heart rate and blood pressure, so careful hemodynamic monitoring is required during its use.

Organic anion transporters (OATs) are membrane transport proteins that are responsible for the cellular uptake and excretion of various organic anions, such as drugs, toxins, and endogenous metabolites. They are found in various tissues, including the kidney, liver, and brain, where they play important roles in the elimination and detoxification of xenobiotics and endogenous compounds.

In the kidney, OATs are located in the basolateral membrane of renal tubular epithelial cells and mediate the uptake of organic anions from the blood into the cells. From there, the anions can be further transported into the urine by other transporters located in the apical membrane. In the liver, OATs are expressed in the sinusoidal membrane of hepatocytes and facilitate the uptake of organic anions from the blood into the liver cells for metabolism and excretion.

There are several isoforms of OATs that have been identified, each with distinct substrate specificities and tissue distributions. Mutations in OAT genes can lead to various diseases, including renal tubular acidosis, hypercalciuria, and drug toxicity. Therefore, understanding the function and regulation of OATs is important for developing strategies to improve drug delivery and reduce adverse drug reactions.

Phlorhizin is not a medical condition or term, but rather a chemical compound. It is a glucoside that can be found in the bark of apple trees and other related plants. Phlorhizin has been studied in the field of medicine for its potential effects on various health conditions. Specifically, it has been shown to inhibit the enzyme called glucose transporter 2 (GLUT2), which is involved in the absorption of glucose in the body. As a result, phlorhizin has been investigated as a potential treatment for diabetes, as it may help regulate blood sugar levels. However, more research is needed to fully understand its effects and safety profile before it can be used as a medical treatment.

Positron-Emission Tomography (PET) is a type of nuclear medicine imaging that uses small amounts of radioactive material, called a radiotracer, to produce detailed, three-dimensional images. This technique measures metabolic activity within the body, such as sugar metabolism, to help distinguish between healthy and diseased tissue, identify cancerous cells, or examine the function of organs.

During a PET scan, the patient is injected with a radiotracer, typically a sugar-based compound labeled with a positron-emitting radioisotope, such as fluorine-18 (^18^F). The radiotracer accumulates in cells that are metabolically active, like cancer cells. As the radiotracer decays, it emits positrons, which then collide with electrons in nearby tissue, producing gamma rays. A special camera, called a PET scanner, detects these gamma rays and uses this information to create detailed images of the body's internal structures and processes.

PET is often used in conjunction with computed tomography (CT) or magnetic resonance imaging (MRI) to provide both functional and anatomical information, allowing for more accurate diagnosis and treatment planning. Common applications include detecting cancer recurrence, staging and monitoring cancer, evaluating heart function, and assessing brain function in conditions like dementia and epilepsy.

Phloretin is a type of chemical compound known as a dihydrochalcone, which is found in certain plants. It is a polyphenolic compound that possesses antioxidant properties and is present in apple skin and other fruits and vegetables. In the medical field, phloretin has been studied for its potential health benefits, including its possible role in preventing or treating conditions such as cancer, diabetes, and cardiovascular disease. However, more research is needed to fully understand its effects and safety profile before it can be recommended for therapeutic use.

A cell membrane, also known as the plasma membrane, is a thin semi-permeable phospholipid bilayer that surrounds all cells in animals, plants, and microorganisms. It functions as a barrier to control the movement of substances in and out of the cell, allowing necessary molecules such as nutrients, oxygen, and signaling molecules to enter while keeping out harmful substances and waste products. The cell membrane is composed mainly of phospholipids, which have hydrophilic (water-loving) heads and hydrophobic (water-fearing) tails. This unique structure allows the membrane to be flexible and fluid, yet selectively permeable. Additionally, various proteins are embedded in the membrane that serve as channels, pumps, receptors, and enzymes, contributing to the cell's overall functionality and communication with its environment.

Glucose intolerance is a condition in which the body has difficulty processing and using glucose, or blood sugar, effectively. This results in higher than normal levels of glucose in the blood after eating, particularly after meals that are high in carbohydrates. Glucose intolerance can be an early sign of developing diabetes, specifically type 2 diabetes, and it may also indicate other metabolic disorders such as prediabetes or insulin resistance.

In a healthy individual, the pancreas produces insulin to help regulate blood sugar levels by facilitating glucose uptake in muscles, fat tissue, and the liver. When someone has glucose intolerance, their body may not produce enough insulin, or their cells may have become less responsive to insulin (insulin resistance), leading to impaired glucose metabolism.

Glucose intolerance can be diagnosed through various tests, including the oral glucose tolerance test (OGTT) and hemoglobin A1c (HbA1c) test. Treatment for glucose intolerance often involves lifestyle modifications such as weight loss, increased physical activity, and a balanced diet with reduced sugar and refined carbohydrate intake. In some cases, medication may be prescribed to help manage blood sugar levels more effectively.

Sodium-glucose transport proteins (SGLTs) are a group of membrane transporters that facilitate the active transport of glucose across cell membranes in various tissues, including the kidneys and intestines. They function by coupling the movement of glucose molecules with sodium ions, using the energy generated by the sodium gradient across the membrane.

The two main types of SGLTs are:

1. SGLT1: This transporter is primarily found in the intestines and plays a crucial role in glucose absorption from food. It has a high affinity for glucose and transports it along with sodium ions, which helps create an electrochemical gradient that drives the transport process.

2. SGLT2: This transporter is mainly located in the early proximal tubules of the kidneys and is responsible for reabsorbing about 90% of the filtered glucose back into the bloodstream. It has a lower affinity for glucose compared to SGLT1 but operates at a higher transport rate, allowing it to efficiently reabsorb large amounts of glucose.

Inhibitors of SGLT2, known as SGLT2 inhibitors or gliflozins, have been developed for the treatment of type 2 diabetes. By blocking SGLT2-mediated glucose reabsorption in the kidneys, these medications promote urinary glucose excretion and help lower blood glucose levels. Examples of SGLT2 inhibitors include canagliflozin, dapagliflozin, and empagliflozin.

Carrier proteins, also known as transport proteins, are a type of protein that facilitates the movement of molecules across cell membranes. They are responsible for the selective and active transport of ions, sugars, amino acids, and other molecules from one side of the membrane to the other, against their concentration gradient. This process requires energy, usually in the form of ATP (adenosine triphosphate).

Carrier proteins have a specific binding site for the molecule they transport, and undergo conformational changes upon binding, which allows them to move the molecule across the membrane. Once the molecule has been transported, the carrier protein returns to its original conformation, ready to bind and transport another molecule.

Carrier proteins play a crucial role in maintaining the balance of ions and other molecules inside and outside of cells, and are essential for many physiological processes, including nerve impulse transmission, muscle contraction, and nutrient uptake.

Adipose tissue, also known as fatty tissue, is a type of connective tissue that is composed mainly of adipocytes (fat cells). It is found throughout the body, but is particularly abundant in the abdominal cavity, beneath the skin, and around organs such as the heart and kidneys.

Adipose tissue serves several important functions in the body. One of its primary roles is to store energy in the form of fat, which can be mobilized and used as an energy source during periods of fasting or exercise. Adipose tissue also provides insulation and cushioning for the body, and produces hormones that help regulate metabolism, appetite, and reproductive function.

There are two main types of adipose tissue: white adipose tissue (WAT) and brown adipose tissue (BAT). WAT is the more common form and is responsible for storing energy as fat. BAT, on the other hand, contains a higher number of mitochondria and is involved in heat production and energy expenditure.

Excessive accumulation of adipose tissue can lead to obesity, which is associated with an increased risk of various health problems such as diabetes, heart disease, and certain types of cancer.

Adipocytes are specialized cells that comprise adipose tissue, also known as fat tissue. They are responsible for storing energy in the form of lipids, particularly triglycerides, and releasing energy when needed through a process called lipolysis. There are two main types of adipocytes: white adipocytes and brown adipocytes. White adipocytes primarily store energy, while brown adipocytes dissipate energy as heat through the action of uncoupling protein 1 (UCP1).

In addition to their role in energy metabolism, adipocytes also secrete various hormones and signaling molecules that contribute to whole-body homeostasis. These include leptin, adiponectin, resistin, and inflammatory cytokines. Dysregulation of adipocyte function has been implicated in the development of obesity, insulin resistance, type 2 diabetes, and cardiovascular disease.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Monocarboxylic acid transporters (MCTs) are a type of membrane transport protein responsible for the transportation of monocarboxylates, such as lactic acid, pyruvic acid, and ketone bodies, across biological membranes. These transporters play crucial roles in various physiological processes, including cellular energy metabolism, pH regulation, and detoxification. In humans, there are 14 different isoforms of MCTs (MCT1-MCT14) that exhibit distinct substrate specificities, tissue distributions, and transport mechanisms. Among them, MCT1, MCT2, MCT3, and MCT4 have been extensively studied in the context of their roles in lactate and pyruvate transport across cell membranes.

MCTs typically function as proton-coupled symporters, meaning they co-transport monocarboxylates and protons in the same direction. This proton coupling allows MCTs to facilitate the uphill transport of monocarboxylates against their concentration gradients, which is essential for maintaining cellular homeostasis and energy production. The activity of MCTs can be modulated by various factors, including pH, membrane potential, and pharmacological agents, making them important targets for therapeutic interventions in several diseases, such as cancer, neurological disorders, and metabolic syndromes.

A symporter is a type of transmembrane protein that functions to transport two or more molecules or ions across a biological membrane in the same direction, simultaneously. This process is called co-transport and it is driven by the concentration gradient of one of the substrates, which is usually an ion such as sodium (Na+) or proton (H+).

Symporters are classified based on the type of energy that drives the transport process. Primary active transporters, such as symporters, use the energy from ATP hydrolysis or from the electrochemical gradient of ions to move substrates against their concentration gradient. In contrast, secondary active transporters use the energy stored in an existing electrochemical gradient of one substrate to drive the transport of another substrate against its own concentration gradient.

Symporters play important roles in various physiological processes, including nutrient uptake, neurotransmitter reuptake, and ion homeostasis. For example, the sodium-glucose transporter (SGLT) is a symporter that co-transports glucose and sodium ions across the intestinal epithelium and the renal proximal tubule, contributing to glucose absorption and regulation of blood glucose levels. Similarly, the dopamine transporter (DAT) is a symporter that co-transports dopamine and sodium ions back into presynaptic neurons, terminating the action of dopamine in the synapse.

Propylamines are a class of organic compounds characterized by the presence of a propylamine group, which is a functional group consisting of a propyl chain (-C3H7) attached to an amino group (-NH2). Propylamines can be primary, secondary, or tertiary, depending on the number of organic substituents attached to the nitrogen atom.

In a medical context, propylamines may refer to certain drugs that contain this functional group and have pharmacological activity. For example, some local anesthetics, such as procaine (Novocain), are derivatives of propylamine. Procaine is a ester of p-aminobenzoic acid and diethylaminoethanol, where the amino group is part of a propylamine chain.

It's important to note that not all compounds containing propylamines have medical applications or uses, as this functional group can also be found in various chemicals with different properties and applications.

Hexokinase is an enzyme that plays a crucial role in the initial step of glucose metabolism, which is the phosphorylation of glucose to form glucose-6-phosphate. This reaction is the first step in most glucose catabolic pathways, including glycolysis, pentose phosphate pathway, and glycogen synthesis.

Hexokinase has a high affinity for glucose, meaning it can bind and phosphorylate glucose even at low concentrations. This property makes hexokinase an important regulator of glucose metabolism in cells. There are four isoforms of hexokinase (I-IV) found in different tissues, with hexokinase IV (also known as glucokinase) being primarily expressed in the liver and pancreas.

In summary, hexokinase is a vital enzyme involved in glucose metabolism, catalyzing the conversion of glucose to glucose-6-phosphate, and playing a crucial role in regulating cellular energy homeostasis.

Hexoses are simple sugars (monosaccharides) that contain six carbon atoms. The most common hexoses include glucose, fructose, and galactose. These sugars play important roles in various biological processes, such as serving as energy sources or forming complex carbohydrates like starch and cellulose. Hexoses are essential for the structure and function of living organisms, including humans.

Glucose oxidase (GOD) is an enzyme that catalyzes the oxidation of D-glucose to D-glucono-1,5-lactone, while reducing oxygen to hydrogen peroxide in the process. This reaction is a part of the metabolic pathway in some organisms that convert glucose into energy. The systematic name for this enzyme is D-glucose:oxygen 1-oxidoreductase.

Glucose oxidase is commonly found in certain fungi, such as Aspergillus niger, and it has various applications in industry, medicine, and research. For instance, it's used in the production of glucose sensors for monitoring blood sugar levels, in the detection and quantification of glucose in food and beverages, and in the development of biosensors for environmental monitoring.

It's worth noting that while glucose oxidase has many applications, it should not be confused with glutathione peroxidase, another enzyme involved in the reduction of hydrogen peroxide to water.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Glycogen is a complex carbohydrate that serves as the primary form of energy storage in animals, fungi, and bacteria. It is a polysaccharide consisting of long, branched chains of glucose molecules linked together by glycosidic bonds. Glycogen is stored primarily in the liver and muscles, where it can be quickly broken down to release glucose into the bloodstream during periods of fasting or increased metabolic demand.

In the liver, glycogen plays a crucial role in maintaining blood glucose levels by releasing glucose when needed, such as between meals or during exercise. In muscles, glycogen serves as an immediate energy source for muscle contractions during intense physical activity. The ability to store and mobilize glycogen is essential for the proper functioning of various physiological processes, including athletic performance, glucose homeostasis, and overall metabolic health.

Affinity labels are chemical probes or reagents that can selectively and covalently bind to a specific protein or biomolecule based on its biological function or activity. These labels contain a functional group that interacts with the target molecule, often through non-covalent interactions such as hydrogen bonding, van der Waals forces, or ionic bonds. Once bound, the label then forms a covalent bond with the target molecule, allowing for its isolation and further study.

Affinity labels are commonly used in biochemistry and molecular biology research to identify and characterize specific proteins, enzymes, or receptors. They can be designed to bind to specific active sites, binding pockets, or other functional regions of a protein, allowing researchers to study the structure-function relationships of these molecules.

One example of an affinity label is a substrate analogue that contains a chemically reactive group. This type of affinity label can be used to identify and characterize enzymes by binding to their active sites and forming a covalent bond with the enzyme. The labeled enzyme can then be purified and analyzed to determine its structure, function, and mechanism of action.

Overall, affinity labels are valuable tools for studying the properties and functions of biological molecules in vitro and in vivo.

Serotonin plasma membrane transport proteins, also known as serotonin transporters (SERTs), are membrane-spanning proteins that play a crucial role in the regulation of serotonergic neurotransmission. They are responsible for the reuptake of serotonin (5-hydroxytryptamine or 5-HT) from the synaptic cleft back into the presynaptic neuron, thereby terminating the signal transmission and allowing for its recycling or degradation.

Structurally, SERTs belong to the family of sodium- and chloride-dependent neurotransmitter transporters and contain 12 transmembrane domains with intracellular N- and C-termini. The binding site for serotonin is located within the transmembrane domain, while the substrate-binding site is formed by residues from both the transmembrane and extracellular loops.

Serotonin transporters are important targets for various psychotropic medications, including selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). These drugs act by blocking the SERT, increasing synaptic concentrations of serotonin, and enhancing serotonergic neurotransmission. Dysregulation of serotonin transporters has been implicated in several neurological and psychiatric disorders, such as major depressive disorder, anxiety disorders, obsessive-compulsive disorder, and substance abuse.

Biological transport, active is the process by which cells use energy to move materials across their membranes from an area of lower concentration to an area of higher concentration. This type of transport is facilitated by specialized proteins called transporters or pumps that are located in the cell membrane. These proteins undergo conformational changes to physically carry the molecules through the lipid bilayer of the membrane, often against their concentration gradient.

Active transport requires energy because it works against the natural tendency of molecules to move from an area of higher concentration to an area of lower concentration, a process known as diffusion. Cells obtain this energy in the form of ATP (adenosine triphosphate), which is produced through cellular respiration.

Examples of active transport include the uptake of glucose and amino acids into cells, as well as the secretion of hormones and neurotransmitters. The sodium-potassium pump, which helps maintain resting membrane potential in nerve and muscle cells, is a classic example of an active transporter.

Dopamine plasma membrane transport proteins, also known as dopamine transporters (DAT), are a type of protein found in the cell membrane that play a crucial role in the regulation of dopamine neurotransmission. They are responsible for the reuptake of dopamine from the synaptic cleft back into the presynaptic neuron, thereby terminating the signal transduction of dopamine and regulating the amount of dopamine available for further release.

Dopamine transporters belong to the family of sodium-dependent neurotransmitter transporters and are encoded by the SLC6A3 gene in humans. Abnormalities in dopamine transporter function have been implicated in several neurological and psychiatric disorders, including Parkinson's disease, attention deficit hyperactivity disorder (ADHD), and substance use disorders.

In summary, dopamine plasma membrane transport proteins are essential for the regulation of dopamine neurotransmission by mediating the reuptake of dopamine from the synaptic cleft back into the presynaptic neuron.

Glycolysis is a fundamental metabolic pathway that occurs in the cytoplasm of cells, consisting of a series of biochemical reactions. It's the process by which a six-carbon glucose molecule is broken down into two three-carbon pyruvate molecules. This process generates a net gain of two ATP molecules (the main energy currency in cells), two NADH molecules, and two water molecules.

Glycolysis can be divided into two stages: the preparatory phase (or 'energy investment' phase) and the payoff phase (or 'energy generation' phase). During the preparatory phase, glucose is phosphorylated twice to form glucose-6-phosphate and then converted to fructose-1,6-bisphosphate. These reactions consume two ATP molecules but set up the subsequent breakdown of fructose-1,6-bisphosphate into triose phosphates in the payoff phase. In this second stage, each triose phosphate is further oxidized and degraded to produce one pyruvate molecule, one NADH molecule, and one ATP molecule through substrate-level phosphorylation.

Glycolysis does not require oxygen to proceed; thus, it can occur under both aerobic (with oxygen) and anaerobic (without oxygen) conditions. In the absence of oxygen, the pyruvate produced during glycolysis is further metabolized through fermentation pathways such as lactic acid fermentation or alcohol fermentation to regenerate NAD+, which is necessary for glycolysis to continue.

In summary, glycolysis is a crucial process in cellular energy metabolism, allowing cells to convert glucose into ATP and other essential molecules while also serving as a starting point for various other biochemical pathways.

Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).

The Western blotting procedure involves several steps:

1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.

Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Excitatory Amino Acid Transporter 2 (EAAT2) is a type of glutamate transporter protein found in the membranes of glial cells in the central nervous system. Glutamate is the primary excitatory neurotransmitter in the brain, and its levels must be carefully regulated to maintain normal neuronal function and survival. EAAT2 plays a critical role in this regulation by removing excess glutamate from the synaptic cleft and returning it to glial cells for storage or breakdown.

EAAT2 is responsible for the majority of glutamate reuptake in the brain, and its expression and function are crucial for maintaining proper neuronal excitability and preventing excitotoxicity, a form of neurodegeneration that can occur when glutamate levels become too high. Mutations or dysfunction in EAAT2 have been implicated in several neurological disorders, including amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and epilepsy.

Skeletal muscle, also known as striated or voluntary muscle, is a type of muscle that is attached to bones by tendons or aponeuroses and functions to produce movements and support the posture of the body. It is composed of long, multinucleated fibers that are arranged in parallel bundles and are characterized by alternating light and dark bands, giving them a striped appearance under a microscope. Skeletal muscle is under voluntary control, meaning that it is consciously activated through signals from the nervous system. It is responsible for activities such as walking, running, jumping, and lifting objects.

'Gene expression regulation' refers to the processes that control whether, when, and where a particular gene is expressed, meaning the production of a specific protein or functional RNA encoded by that gene. This complex mechanism can be influenced by various factors such as transcription factors, chromatin remodeling, DNA methylation, non-coding RNAs, and post-transcriptional modifications, among others. Proper regulation of gene expression is crucial for normal cellular function, development, and maintaining homeostasis in living organisms. Dysregulation of gene expression can lead to various diseases, including cancer and genetic disorders.

An azide is a chemical compound that contains the functional group -N=N+=N-, which consists of three nitrogen atoms joined by covalent bonds. In organic chemistry, azides are often used as reagents in various chemical reactions, such as the azide-alkyne cycloaddition (also known as the "click reaction").

In medical terminology, azides may refer to a class of drugs that contain an azido group and are used for their pharmacological effects. For example, sodium nitroprusside is a vasodilator drug that contains an azido group and is used to treat hypertensive emergencies.

However, it's worth noting that azides can also be toxic and potentially explosive under certain conditions, so they must be handled with care in laboratory settings.

3T3-L1 cells are a widely used cell line in biomedical research, particularly in the study of adipocytes (fat cells) and adipose tissue. These cells are derived from mouse embryo fibroblasts and have the ability to differentiate into adipocytes under specific culture conditions.

When 3T3-L1 cells are exposed to a cocktail of hormones and growth factors, they undergo a process called adipogenesis, during which they differentiate into mature adipocytes. These differentiated cells exhibit many characteristics of fat cells, including the accumulation of lipid droplets, expression of adipocyte-specific genes and proteins, and the ability to respond to hormones such as insulin.

Researchers use 3T3-L1 cells to study various aspects of adipocyte biology, including the regulation of fat metabolism, the development of obesity and related metabolic disorders, and the effects of drugs or other compounds on adipose tissue function. However, it is important to note that because these cells are derived from mice, they may not always behave exactly the same way as human adipocytes, so results obtained using 3T3-L1 cells must be validated in human cell lines or animal models before they can be applied to human health.

Cystinyl aminopeptidase is a type of enzyme that belongs to the family of metallopeptidases. Its primary function is to catalyze the removal of cystinyl residues from the N-terminus of polypeptides, proteins, and smaller peptides. This enzyme plays an essential role in protein metabolism and turnover within cells.

Cystinyl aminopeptidase is widely distributed in various tissues throughout the body, including the liver, kidney, and brain. It has been identified as a potential therapeutic target for several diseases, such as cancer, neurodegenerative disorders, and viral infections, due to its involvement in regulating intracellular protein degradation and processing.

The enzyme's active site contains a zinc ion that is crucial for its catalytic activity. Inhibitors of cystinyl aminopeptidase can be used as pharmaceutical agents to modulate the enzyme's function in disease states, although further research is needed to fully understand the potential benefits and risks associated with such therapies.

Hypoglycemic agents are a class of medications that are used to lower blood glucose levels in the treatment of diabetes mellitus. These medications work by increasing insulin sensitivity, stimulating insulin release from the pancreas, or inhibiting glucose production in the liver. Examples of hypoglycemic agents include sulfonylureas, meglitinides, biguanides, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists. It's important to note that the term "hypoglycemic" refers to a condition of abnormally low blood glucose levels, but in this context, the term is used to describe agents that are used to treat high blood glucose levels (hyperglycemia) associated with diabetes.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

Glycosides are organic compounds that consist of a glycone (a sugar component) linked to a non-sugar component, known as an aglycone, via a glycosidic bond. They can be found in various plants, microorganisms, and some animals. Depending on the nature of the aglycone, glycosides can be classified into different types, such as anthraquinone glycosides, cardiac glycosides, and saponin glycosides.

These compounds have diverse biological activities and pharmacological effects. For instance:

* Cardiac glycosides, like digoxin and digitoxin, are used in the treatment of heart failure and certain cardiac arrhythmias due to their positive inotropic (contractility-enhancing) and negative chronotropic (heart rate-slowing) effects on the heart.
* Saponin glycosides have potent detergent properties and can cause hemolysis (rupture of red blood cells). They are used in various industries, including cosmetics and food processing, and have potential applications in drug delivery systems.
* Some glycosides, like amygdalin found in apricot kernels and bitter almonds, can release cyanide upon hydrolysis, making them potentially toxic.

It is important to note that while some glycosides have therapeutic uses, others can be harmful or even lethal if ingested or otherwise introduced into the body in large quantities.

3T3 cells are a type of cell line that is commonly used in scientific research. The name "3T3" is derived from the fact that these cells were developed by treating mouse embryo cells with a chemical called trypsin and then culturing them in a flask at a temperature of 37 degrees Celsius.

Specifically, 3T3 cells are a type of fibroblast, which is a type of cell that is responsible for producing connective tissue in the body. They are often used in studies involving cell growth and proliferation, as well as in toxicity tests and drug screening assays.

One particularly well-known use of 3T3 cells is in the 3T3-L1 cell line, which is a subtype of 3T3 cells that can be differentiated into adipocytes (fat cells) under certain conditions. These cells are often used in studies of adipose tissue biology and obesity.

It's important to note that because 3T3 cells are a type of immortalized cell line, they do not always behave exactly the same way as primary cells (cells that are taken directly from a living organism). As such, researchers must be careful when interpreting results obtained using 3T3 cells and consider any potential limitations or artifacts that may arise due to their use.

Amino acid transport systems refer to the various membrane transport proteins that are responsible for the active or passive translocation of amino acids across cell membranes in the body. These transport systems play a crucial role in maintaining amino acid homeostasis within cells and regulating their availability for protein synthesis, neurotransmission, and other physiological processes.

There are several distinct amino acid transport systems, each with its own specificity for particular types of amino acids or related molecules. These systems can be classified based on their energy requirements, substrate specificity, and membrane localization. Some of the major amino acid transport systems include:

1. System A - This is a sodium-dependent transport system that primarily transports small, neutral amino acids such as alanine, serine, and proline. It has several subtypes (ASC, A, and AN) with different substrate affinities and kinetic properties.
2. System L - This is a sodium-independent transport system that transports large, neutral amino acids such as leucine, isoleucine, valine, phenylalanine, and tryptophan. It has several subtypes (L1, L2, and y+L) with different substrate specificities and transport mechanisms.
3. System B0 - This is a sodium-dependent transport system that transports both neutral and basic amino acids such as arginine, lysine, and ornithine. It has several subtypes (B0,+, B0-, and b0,+) with different substrate affinities and kinetic properties.
4. System y+ - This is a sodium-independent transport system that transports primarily basic amino acids such as arginine, lysine, and ornithine. It has several subtypes (y+L, y+, b0,+) with different substrate specificities and transport mechanisms.
5. System X-AG - This is a sodium-independent antiporter system that exchanges glutamate and aspartate for neutral amino acids such as cystine, serine, and threonine. It plays an essential role in maintaining redox homeostasis by regulating the intracellular levels of cysteine, a precursor of glutathione.

These transport systems are critical for maintaining cellular homeostasis and regulating various physiological processes such as protein synthesis, neurotransmission, and immune function. Dysregulation of these transport systems has been implicated in several diseases, including cancer, neurological disorders, and cardiovascular disease. Therefore, understanding the molecular mechanisms underlying these transport systems is essential for developing novel therapeutic strategies to treat these conditions.

Disaccharides are a type of carbohydrate that is made up of two monosaccharide units bonded together. Monosaccharides are simple sugars, such as glucose, fructose, or galactose. When two monosaccharides are joined together through a condensation reaction, they form a disaccharide.

The most common disaccharides include:

* Sucrose (table sugar), which is composed of one glucose molecule and one fructose molecule.
* Lactose (milk sugar), which is composed of one glucose molecule and one galactose molecule.
* Maltose (malt sugar), which is composed of two glucose molecules.

Disaccharides are broken down into their component monosaccharides during digestion by enzymes called disaccharidases, which are located in the brush border of the small intestine. These enzymes catalyze the hydrolysis of the glycosidic bond that links the two monosaccharides together, releasing them to be absorbed into the bloodstream and used for energy.

Disorders of disaccharide digestion and absorption can lead to various symptoms, such as bloating, diarrhea, and abdominal pain. For example, lactose intolerance is a common condition in which individuals lack sufficient levels of the enzyme lactase, leading to an inability to properly digest lactose and resulting in gastrointestinal symptoms.

A cell line is a culture of cells that are grown in a laboratory for use in research. These cells are usually taken from a single cell or group of cells, and they are able to divide and grow continuously in the lab. Cell lines can come from many different sources, including animals, plants, and humans. They are often used in scientific research to study cellular processes, disease mechanisms, and to test new drugs or treatments. Some common types of human cell lines include HeLa cells (which come from a cancer patient named Henrietta Lacks), HEK293 cells (which come from embryonic kidney cells), and HUVEC cells (which come from umbilical vein endothelial cells). It is important to note that cell lines are not the same as primary cells, which are cells that are taken directly from a living organism and have not been grown in the lab.

Protein transport, in the context of cellular biology, refers to the process by which proteins are actively moved from one location to another within or between cells. This is a crucial mechanism for maintaining proper cell function and regulation.

Intracellular protein transport involves the movement of proteins within a single cell. Proteins can be transported across membranes (such as the nuclear envelope, endoplasmic reticulum, Golgi apparatus, or plasma membrane) via specialized transport systems like vesicles and transport channels.

Intercellular protein transport refers to the movement of proteins from one cell to another, often facilitated by exocytosis (release of proteins in vesicles) and endocytosis (uptake of extracellular substances via membrane-bound vesicles). This is essential for communication between cells, immune response, and other physiological processes.

It's important to note that any disruption in protein transport can lead to various diseases, including neurological disorders, cancer, and metabolic conditions.

Organic Cation Transporter 1 (OCT1) is a protein that belongs to the solute carrier family 22 (SLC22A). It is primarily expressed in the liver and plays an essential role in the uptake and elimination of various organic cations, including many drugs, from the systemic circulation into hepatocytes. OCT1 also transports some endogenous substances such as neurotransmitters and hormones. Mutations or variants in the OCT1 gene can affect drug response and disposition, making it an important factor to consider in personalized medicine.

Fructose is a simple monosaccharide, also known as "fruit sugar." It is a naturally occurring carbohydrate that is found in fruits, vegetables, and honey. Fructose has the chemical formula C6H12O6 and is a hexose, or six-carbon sugar.

Fructose is absorbed directly into the bloodstream during digestion and is metabolized primarily in the liver. It is sweeter than other sugars such as glucose and sucrose (table sugar), which makes it a popular sweetener in many processed foods and beverages. However, consuming large amounts of fructose can have negative health effects, including increasing the risk of obesity, diabetes, and heart disease.

Dehydroascorbic acid (DHAA) is the oxidized form of ascorbic acid, which is more commonly known as vitamin C. It is the oxidation product of ascorbic acid that is formed when the vitamin C molecule loses two electrons and two protons. This conversion can occur naturally in the body or during the processing and storage of food.

DHAA still retains some vitamin C activity, but it is not as biologically active as ascorbic acid. However, DHAA can be reduced back to ascorbic acid in the body by certain enzymes, which allows it to still contribute to maintaining proper levels of this essential nutrient.

DHAA plays a role in various physiological processes, including collagen synthesis, immune function, and antioxidant defense. It is also involved in the metabolism of amino acids, carbohydrates, and lipids. A deficiency in vitamin C can lead to scurvy, a condition characterized by fatigue, joint pain, anemia, and skin changes.

Diabetes Mellitus, Type 2 is a metabolic disorder characterized by high blood glucose (or sugar) levels resulting from the body's inability to produce sufficient amounts of insulin or effectively use the insulin it produces. This form of diabetes usually develops gradually over several years and is often associated with older age, obesity, physical inactivity, family history of diabetes, and certain ethnicities.

In Type 2 diabetes, the body's cells become resistant to insulin, meaning they don't respond properly to the hormone. As a result, the pancreas produces more insulin to help glucose enter the cells. Over time, the pancreas can't keep up with the increased demand, leading to high blood glucose levels and diabetes.

Type 2 diabetes is managed through lifestyle modifications such as weight loss, regular exercise, and a healthy diet. Medications, including insulin therapy, may also be necessary to control blood glucose levels and prevent long-term complications associated with the disease, such as heart disease, nerve damage, kidney damage, and vision loss.

Excitatory Amino Acid Transporter 1 (EAAT1) is a type of glutamate transporter protein found in the membranes of glial cells in the central nervous system. Glutamate is the primary excitatory neurotransmitter in the brain, and its levels must be carefully regulated to maintain normal neuronal function and survival. EAAT1 plays a crucial role in this regulation by transporting glutamate from the synaptic cleft back into the glial cells, where it can be converted to glutamine or stored for later use. In this way, EAAT1 helps to terminate the excitatory signal and prevent excessive accumulation of glutamate in the extracellular space, which can lead to excitotoxicity and neurodegeneration. Mutations in the gene that encodes EAAT1 have been associated with certain neurological disorders, including episodic ataxia type 6 and amyotrophic lateral sclerosis (ALS).

Gene expression is the process by which the information encoded in a gene is used to synthesize a functional gene product, such as a protein or RNA molecule. This process involves several steps: transcription, RNA processing, and translation. During transcription, the genetic information in DNA is copied into a complementary RNA molecule, known as messenger RNA (mRNA). The mRNA then undergoes RNA processing, which includes adding a cap and tail to the mRNA and splicing out non-coding regions called introns. The resulting mature mRNA is then translated into a protein on ribosomes in the cytoplasm through the process of translation.

The regulation of gene expression is a complex and highly controlled process that allows cells to respond to changes in their environment, such as growth factors, hormones, and stress signals. This regulation can occur at various stages of gene expression, including transcriptional activation or repression, RNA processing, mRNA stability, and translation. Dysregulation of gene expression has been implicated in many diseases, including cancer, genetic disorders, and neurological conditions.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Nerve tissue proteins are specialized proteins found in the nervous system that provide structural and functional support to nerve cells, also known as neurons. These proteins include:

1. Neurofilaments: These are type IV intermediate filaments that provide structural support to neurons and help maintain their shape and size. They are composed of three subunits - NFL (light), NFM (medium), and NFH (heavy).

2. Neuronal Cytoskeletal Proteins: These include tubulins, actins, and spectrins that provide structural support to the neuronal cytoskeleton and help maintain its integrity.

3. Neurotransmitter Receptors: These are specialized proteins located on the postsynaptic membrane of neurons that bind neurotransmitters released by presynaptic neurons, triggering a response in the target cell.

4. Ion Channels: These are transmembrane proteins that regulate the flow of ions across the neuronal membrane and play a crucial role in generating and transmitting electrical signals in neurons.

5. Signaling Proteins: These include enzymes, receptors, and adaptor proteins that mediate intracellular signaling pathways involved in neuronal development, differentiation, survival, and death.

6. Adhesion Proteins: These are cell surface proteins that mediate cell-cell and cell-matrix interactions, playing a crucial role in the formation and maintenance of neural circuits.

7. Extracellular Matrix Proteins: These include proteoglycans, laminins, and collagens that provide structural support to nerve tissue and regulate neuronal migration, differentiation, and survival.

Leishmania enriettii is a species of protozoan parasite that belongs to the genus Leishmania. This genus includes several species that are known to cause different forms of leishmaniasis, a group of diseases that affect various organs and tissues in humans and animals.

Leishmania enriettii is primarily associated with causing cutaneous leishmaniasis, a skin infection characterized by the development of ulcers or lesions on the exposed parts of the body such as the face, arms, and legs. The parasite is transmitted to humans through the bite of infected female sandflies, which serve as vectors for the disease.

The parasite's life cycle involves two main stages: the promastigote stage, which occurs in the sandfly vector, and the amastigote stage, which occurs in the mammalian host. In the sandfly, the parasites multiply in the midgut and transform into infective promastigotes. When the infected sandfly bites a human or other mammalian host, it injects the promastigotes into the skin, where they are taken up by immune cells called macrophages. Once inside the macrophages, the parasites transform into amastigotes and multiply within the phagolysosome, an organelle within the macrophage that is responsible for breaking down foreign particles.

The clinical manifestations of cutaneous leishmaniasis caused by Leishmania enriettii are typically milder than those caused by other Leishmania species. The lesions tend to be smaller and heal more quickly, often without leaving scars. However, in some cases, the infection can lead to more severe forms of the disease, such as mucocutaneous leishmaniasis, which affects the mucous membranes of the nose, mouth, and throat.

Diagnosis of Leishmania enriettii infection is typically based on clinical symptoms, epidemiological data, and laboratory tests such as direct observation of parasites in tissue samples or detection of parasite DNA using molecular techniques. Treatment usually involves the use of antiparasitic drugs such as pentavalent antimonials, amphotericin B, or miltefosine.

Glucokinase is an enzyme that plays a crucial role in regulating glucose metabolism. It is primarily found in the liver, pancreas, and brain. In the pancreas, glucokinase helps to trigger the release of insulin in response to rising blood glucose levels. In the liver, it plays a key role in controlling glucose storage and production.

Glucokinase has a unique property among hexokinases (enzymes that phosphorylate six-carbon sugars) in that it is not inhibited by its product, glucose-6-phosphate. This allows it to continue functioning even when glucose levels are high, making it an important regulator of glucose metabolism.

Defects in the gene that codes for glucokinase can lead to several types of inherited diabetes and other metabolic disorders.

I couldn't find a medical definition specifically for "Diabetes Mellitus, Experimental." However, I can provide you with information about experimental diabetes research and its relevance to understanding the disease.

Experimental diabetes models are used in biomedical research to study the pathophysiology of diabetes mellitus and to test potential therapies or treatments. These models can be broadly categorized into two types: chemically-induced and genetically modified.

1. Chemically-induced diabetes models: These involve administering chemicals, such as alloxan or streptozotocin, to animals (commonly mice or rats) to destroy their pancreatic β-cells, which produce insulin. This results in hyperglycemia and symptoms similar to those seen in type 1 diabetes in humans.
2. Genetically modified diabetes models: These involve altering the genes of animals (commonly mice) to create a diabetes phenotype. Examples include non-obese diabetic (NOD) mice, which develop an autoimmune form of diabetes similar to human type 1 diabetes, and various strains of obese mice with insulin resistance, such as ob/ob or db/db mice, which model aspects of type 2 diabetes.

These experimental models help researchers better understand the mechanisms behind diabetes development and progression, identify new therapeutic targets, and test potential treatments before moving on to human clinical trials. However, it's essential to recognize that these models may not fully replicate all aspects of human diabetes, so findings from animal studies should be interpreted with caution.

Membrane proteins are a type of protein that are embedded in the lipid bilayer of biological membranes, such as the plasma membrane of cells or the inner membrane of mitochondria. These proteins play crucial roles in various cellular processes, including:

1. Cell-cell recognition and signaling
2. Transport of molecules across the membrane (selective permeability)
3. Enzymatic reactions at the membrane surface
4. Energy transduction and conversion
5. Mechanosensation and signal transduction

Membrane proteins can be classified into two main categories: integral membrane proteins, which are permanently associated with the lipid bilayer, and peripheral membrane proteins, which are temporarily or loosely attached to the membrane surface. Integral membrane proteins can further be divided into three subcategories based on their topology:

1. Transmembrane proteins, which span the entire width of the lipid bilayer with one or more alpha-helices or beta-barrels.
2. Lipid-anchored proteins, which are covalently attached to lipids in the membrane via a glycosylphosphatidylinositol (GPI) anchor or other lipid modifications.
3. Monotopic proteins, which are partially embedded in the membrane and have one or more domains exposed to either side of the bilayer.

Membrane proteins are essential for maintaining cellular homeostasis and are targets for various therapeutic interventions, including drug development and gene therapy. However, their structural complexity and hydrophobicity make them challenging to study using traditional biochemical methods, requiring specialized techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and single-particle cryo-electron microscopy (cryo-EM).

Norepinephrine plasma membrane transport proteins, also known as norepinephrine transporters (NET), are membrane-bound proteins that play a crucial role in the regulation of neurotransmission. They are responsible for the reuptake of norepinephrine from the synaptic cleft back into the presynaptic neuron, thereby terminating the signal transmission and preventing excessive stimulation of postsynaptic receptors.

The norepinephrine transporter is a member of the sodium-dependent neurotransmitter transporter family and functions as an antiporter, exchanging one intracellular sodium ion for two extracellular sodium ions along with the transport of norepinephrine. This sodium gradient provides the energy required for the active transport process.

Dysregulation of norepinephrine plasma membrane transport proteins has been implicated in various neurological and psychiatric disorders, such as attention deficit hyperactivity disorder (ADHD), depression, and post-traumatic stress disorder (PTSD). Therefore, understanding the function and regulation of these transporters is essential for developing novel therapeutic strategies to treat these conditions.

The liver is a large, solid organ located in the upper right portion of the abdomen, beneath the diaphragm and above the stomach. It plays a vital role in several bodily functions, including:

1. Metabolism: The liver helps to metabolize carbohydrates, fats, and proteins from the food we eat into energy and nutrients that our bodies can use.
2. Detoxification: The liver detoxifies harmful substances in the body by breaking them down into less toxic forms or excreting them through bile.
3. Synthesis: The liver synthesizes important proteins, such as albumin and clotting factors, that are necessary for proper bodily function.
4. Storage: The liver stores glucose, vitamins, and minerals that can be released when the body needs them.
5. Bile production: The liver produces bile, a digestive juice that helps to break down fats in the small intestine.
6. Immune function: The liver plays a role in the immune system by filtering out bacteria and other harmful substances from the blood.

Overall, the liver is an essential organ that plays a critical role in maintaining overall health and well-being.

"Wistar rats" are a strain of albino rats that are widely used in laboratory research. They were developed at the Wistar Institute in Philadelphia, USA, and were first introduced in 1906. Wistar rats are outbred, which means that they are genetically diverse and do not have a fixed set of genetic characteristics like inbred strains.

Wistar rats are commonly used as animal models in biomedical research because of their size, ease of handling, and relatively low cost. They are used in a wide range of research areas, including toxicology, pharmacology, nutrition, cancer, cardiovascular disease, and behavioral studies. Wistar rats are also used in safety testing of drugs, medical devices, and other products.

Wistar rats are typically larger than many other rat strains, with males weighing between 500-700 grams and females weighing between 250-350 grams. They have a lifespan of approximately 2-3 years. Wistar rats are also known for their docile and friendly nature, making them easy to handle and work with in the laboratory setting.

The Islets of Langerhans are clusters of specialized cells within the pancreas, an organ located behind the stomach. These islets are named after Paul Langerhans, who first identified them in 1869. They constitute around 1-2% of the total mass of the pancreas and are distributed throughout its substance.

The Islets of Langerhans contain several types of cells, including:

1. Alpha (α) cells: These produce and release glucagon, a hormone that helps to regulate blood sugar levels by promoting the conversion of glycogen to glucose in the liver when blood sugar levels are low.
2. Beta (β) cells: These produce and release insulin, a hormone that promotes the uptake and utilization of glucose by cells throughout the body, thereby lowering blood sugar levels.
3. Delta (δ) cells: These produce and release somatostatin, a hormone that inhibits the release of both insulin and glucagon and helps regulate their secretion in response to changing blood sugar levels.
4. PP cells (gamma or γ cells): These produce and release pancreatic polypeptide, which plays a role in regulating digestive enzyme secretion and gastrointestinal motility.

Dysfunction of the Islets of Langerhans can lead to various endocrine disorders, such as diabetes mellitus, where insulin-producing beta cells are damaged or destroyed, leading to impaired blood sugar regulation.

Organic anion transporters (OATs) are membrane transport proteins that facilitate the movement of organic anions across biological membranes. The term "sodium-independent" refers to the fact that these particular OATs do not require the presence of sodium ions for their transport function.

Sodium-independent OATs are a subgroup of the larger family of organic anion transporters, which also includes sodium-dependent OATs. These transporters play important roles in the elimination and distribution of various endogenous and exogenous organic anions, including drugs, toxins, and metabolic waste products.

In the kidney, for example, sodium-independent OATs are located in the basolateral membrane of renal tubular epithelial cells and are involved in the secretion and reabsorption of organic anions. They help maintain the balance of these compounds in the body by facilitating their movement into and out of cells, often in conjunction with other transport proteins that move these compounds across the apical membrane of the tubular epithelial cells.

Overall, sodium-independent OATs are important for the proper functioning of various physiological processes, including drug disposition, toxin elimination, and waste product clearance.

Cation transport proteins are a type of membrane protein that facilitate the movement of cations (positively charged ions) across biological membranes. These proteins play a crucial role in maintaining ion balance and electrical excitability within cells, as well as in various physiological processes such as nutrient uptake, waste elimination, and signal transduction.

There are several types of cation transport proteins, including:

1. Ion channels: These are specialized protein structures that form a pore or channel through the membrane, allowing ions to pass through rapidly and selectively. They can be either voltage-gated or ligand-gated, meaning they open in response to changes in electrical potential or binding of specific molecules, respectively.

2. Ion pumps: These are active transport proteins that use energy from ATP hydrolysis to move ions against their electrochemical gradient, effectively pumping them from one side of the membrane to the other. Examples include the sodium-potassium pump (Na+/K+-ATPase) and calcium pumps (Ca2+ ATPase).

3. Ion exchangers: These are antiporter proteins that facilitate the exchange of one ion for another across the membrane, maintaining electroneutrality. For example, the sodium-proton exchanger (NHE) moves a proton into the cell in exchange for a sodium ion being moved out.

4. Symporters: These are cotransporter proteins that move two or more ions together in the same direction, often coupled with the transport of a solute molecule. An example is the sodium-glucose cotransporter (SGLT), which facilitates glucose uptake into cells by coupling its movement with that of sodium ions.

Collectively, cation transport proteins help maintain ion homeostasis and contribute to various cellular functions, including electrical signaling, enzyme regulation, and metabolic processes. Dysfunction in these proteins can lead to a range of diseases, such as neurological disorders, cardiovascular disease, and kidney dysfunction.

Microsomes are subcellular membranous vesicles that are obtained as a byproduct during the preparation of cellular homogenates. They are not naturally occurring structures within the cell, but rather formed due to fragmentation of the endoplasmic reticulum (ER) during laboratory procedures. Microsomes are widely used in various research and scientific studies, particularly in the fields of biochemistry and pharmacology.

Microsomes are rich in enzymes, including the cytochrome P450 system, which is involved in the metabolism of drugs, toxins, and other xenobiotics. These enzymes play a crucial role in detoxifying foreign substances and eliminating them from the body. As such, microsomes serve as an essential tool for studying drug metabolism, toxicity, and interactions, allowing researchers to better understand and predict the effects of various compounds on living organisms.

Blood glucose self-monitoring is the regular measurement of blood glucose levels performed by individuals with diabetes to manage their condition. This process involves using a portable device, such as a glucometer or continuous glucose monitor (CGM), to measure the amount of glucose present in a small sample of blood, usually obtained through a fingerstick.

The primary purpose of self-monitoring is to help individuals with diabetes understand how various factors, such as food intake, physical activity, medication, and stress, affect their blood glucose levels. By tracking these patterns, they can make informed decisions about adjusting their diet, exercise, or medication regimens to maintain optimal glycemic control and reduce the risk of long-term complications associated with diabetes.

Self-monitoring is an essential component of diabetes self-management and education, enabling individuals to take an active role in their healthcare. Regular monitoring also allows healthcare professionals to assess a patient's adherence to their treatment plan and make necessary adjustments based on the data collected.

Organic cation transport proteins (OCTs) are a group of membrane transporters that facilitate the movement of organic cations across biological membranes. These transporters play an essential role in the absorption, distribution, and elimination of various endogenous and exogenous substances, including drugs and toxins.

There are four main types of OCTs, namely OCT1, OCT2, OCT3, and OCTN1 (also known as novel organic cation transporter 1 or OCT6). These proteins belong to the solute carrier (SLC) family, specifically SLC22A.

OCTs have a broad substrate specificity and can transport various organic cations, such as neurotransmitters (e.g., serotonin, dopamine, histamine), endogenous compounds (e.g., creatinine, choline), and drugs (e.g., metformin, quinidine, morphine). The transport process is typically sodium-independent and can occur in both directions, depending on the concentration gradient of the substrate.

OCTs are widely expressed in various tissues, including the liver, kidney, intestine, brain, heart, and placenta. Their expression patterns and functions vary among different OCT types, contributing to their diverse roles in physiology and pharmacology. Dysfunction of OCTs has been implicated in several diseases, such as drug toxicity, neurodegenerative disorders, and cancer.

In summary, organic cation transport proteins are membrane transporters that facilitate the movement of organic cations across biological membranes, playing crucial roles in the absorption, distribution, and elimination of various substances, including drugs and toxins.

A muscle is a soft tissue in our body that contracts to produce force and motion. It is composed mainly of specialized cells called muscle fibers, which are bound together by connective tissue. There are three types of muscles: skeletal (voluntary), smooth (involuntary), and cardiac. Skeletal muscles attach to bones and help in movement, while smooth muscles are found within the walls of organs and blood vessels, helping with functions like digestion and circulation. Cardiac muscle is the specific type that makes up the heart, allowing it to pump blood throughout the body.

4-Chloromercuribenzenesulfonate is a chemical compound with the formula C6H5ClHgSO3. It is an organomercury compound, where mercury is bonded to a phenyl ring and a sulfonate group. This compound is an white crystalline powder that is soluble in water and denser than water.

It has been used historically as a diuretic and antiseptic, but its use in medicine has been discontinued due to the toxicity of mercury. Exposure to mercury can have serious health consequences, including damage to the nervous system, kidneys, and digestive system. Therefore, handling and disposal of 4-chloromercuribenzenesulfonate should be done with caution and in accordance with local regulations for hazardous materials.

"Inbred strains of rats" are genetically identical rodents that have been produced through many generations of brother-sister mating. This results in a high degree of homozygosity, where the genes at any particular locus in the genome are identical in all members of the strain.

Inbred strains of rats are widely used in biomedical research because they provide a consistent and reproducible genetic background for studying various biological phenomena, including the effects of drugs, environmental factors, and genetic mutations on health and disease. Additionally, inbred strains can be used to create genetically modified models of human diseases by introducing specific mutations into their genomes.

Some commonly used inbred strains of rats include the Wistar Kyoto (WKY), Sprague-Dawley (SD), and Fischer 344 (F344) rat strains. Each strain has its own unique genetic characteristics, making them suitable for different types of research.

Nucleoside transport proteins (NTTs) are membrane-bound proteins responsible for the facilitated diffusion of nucleosides and related deoxynucleosides across the cell membrane. These proteins play a crucial role in the uptake of nucleosides, which serve as precursors for DNA and RNA synthesis, as well as for the salvage of nucleotides in the cell.

There are two main types of NTTs: concentrative (or sodium-dependent) nucleoside transporters (CNTs) and equilibrative (or sodium-independent) nucleoside transporters (ENTs). CNTs mainly facilitate the uptake of nucleosides against a concentration gradient, using the energy derived from the sodium ion gradient. In contrast, ENTs mediate bidirectional transport, allowing for the equalization of intracellular and extracellular nucleoside concentrations.

Nucleoside transport proteins have been identified in various organisms, including humans, and are involved in numerous physiological processes, such as cell proliferation, differentiation, and survival. Dysregulation of NTTs has been implicated in several pathological conditions, including cancer and viral infections, making them potential targets for therapeutic intervention.

Fasting is defined in medical terms as the abstinence from food or drink for a period of time. This practice is often recommended before certain medical tests or procedures, as it helps to ensure that the results are not affected by recent eating or drinking.

In some cases, fasting may also be used as a therapeutic intervention, such as in the management of seizures or other neurological conditions. Fasting can help to lower blood sugar and insulin levels, which can have a variety of health benefits. However, it is important to note that prolonged fasting can also have negative effects on the body, including malnutrition, dehydration, and electrolyte imbalances.

Fasting is also a spiritual practice in many religions, including Christianity, Islam, Buddhism, and Hinduism. In these contexts, fasting is often seen as a way to purify the mind and body, to focus on spiritual practices, or to express devotion or mourning.

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

"Xenopus laevis" is not a medical term itself, but it refers to a specific species of African clawed frog that is often used in scientific research, including biomedical and developmental studies. Therefore, its relevance to medicine comes from its role as a model organism in laboratories.

In a broader sense, Xenopus laevis has contributed significantly to various medical discoveries, such as the understanding of embryonic development, cell cycle regulation, and genetic research. For instance, the Nobel Prize in Physiology or Medicine was awarded in 1963 to John R. B. Gurdon and Sir Michael J. Bishop for their discoveries concerning the genetic mechanisms of organism development using Xenopus laevis as a model system.

GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the mammalian central nervous system. GABA plasma membrane transport proteins, also known as GATs (GABA transporters), are a family of membrane-spanning proteins responsible for the uptake of GABA from the extracellular space into neurons and glial cells.

There are four main subtypes of GATs in mammals, named GAT1, GAT2, GAT3, and Betaine/GABA transporter 1 (BGT1). These transport proteins play a crucial role in terminating the synaptic transmission of GABA and regulating its concentration in the extracellular space. They also help maintain the balance between excitation and inhibition in the central nervous system.

GATs are targets for various pharmacological interventions, as modulation of their activity can affect GABAergic neurotransmission and have therapeutic potential in treating several neurological disorders, such as epilepsy, anxiety, and chronic pain.

Sodium-Glucose Transporter 2 (SGLT2) is a medically recognized term referring to a specific protein that plays a crucial role in the reabsorption of glucose in the kidneys. It is a type of membrane transport protein located in the proximal convoluted tubule of the nephron, where it actively transports glucose and sodium ions from the urine back into the bloodstream.

In healthy individuals, SGLT2 is responsible for reabsorbing about 90% of the filtered glucose, maintaining normal blood glucose levels. However, in certain medical conditions like diabetes, the amount of glucose in the blood can be significantly higher than normal. As a result, SGLT2 inhibitors have been developed as a class of medications to block this transporter's function, thereby increasing glucose excretion through urine and lowering blood glucose levels.

SGLT2 inhibitors are often prescribed in combination with other diabetes medications to help manage type 2 diabetes more effectively. Common SGLT2 inhibitors include canagliflozin, dapagliflozin, and empagliflozin.

Glucose 1-Dehydrogenase (G1DH) is an enzyme that catalyzes the oxidation of β-D-glucose into D-glucono-1,5-lactone and reduces the cofactor NAD+ into NADH. This reaction plays a role in various biological processes, including glucose sensing and detoxification of reactive carbonyl species. G1DH is found in many organisms, including humans, and has several isoforms with different properties and functions.

Lactic acid, also known as 2-hydroxypropanoic acid, is a chemical compound that plays a significant role in various biological processes. In the context of medicine and biochemistry, lactic acid is primarily discussed in relation to muscle metabolism and cellular energy production. Here's a medical definition for lactic acid:

Lactic acid (LA): A carboxylic acid with the molecular formula C3H6O3 that plays a crucial role in anaerobic respiration, particularly during strenuous exercise or conditions of reduced oxygen availability. It is formed through the conversion of pyruvate, catalyzed by the enzyme lactate dehydrogenase (LDH), when there is insufficient oxygen to complete the final step of cellular respiration in the Krebs cycle. The accumulation of lactic acid can lead to acidosis and muscle fatigue. Additionally, lactic acid serves as a vital intermediary in various metabolic pathways and is involved in the production of glucose through gluconeogenesis in the liver.

Neutral amino acid transport systems refer to a group of membrane transporters that facilitate the movement of neutral amino acids across cell membranes. Neutral amino acids are those that have a neutral charge at physiological pH and include amino acids such as alanine, serine, threonine, valine, leucine, isoleucine, methionine, cysteine, tyrosine, phenylalanine, and tryptophan.

There are several different transport systems that have been identified for neutral amino acids, each with its own specificity and affinity for different amino acids. Some of the major neutral amino acid transport systems include:

1. System A: This transporter preferentially transports small, neutral amino acids such as alanine, serine, and threonine. It is found in many tissues, including the intestines, kidneys, and brain.
2. System B0+: This transporter preferentially transports large, neutral amino acids such as leucine, isoleucine, valine, methionine, and phenylalanine. It is found in many tissues, including the intestines, kidneys, and brain.
3. System L: This transporter preferentially transports large, neutral amino acids such as leucine, isoleucine, valine, methionine, and phenylalanine. It is found in many tissues, including the intestines, kidneys, and brain.
4. System y+: This transporter preferentially transports cationic amino acids such as lysine and arginine, but it can also transport some neutral amino acids. It is found in many tissues, including the intestines, kidneys, and brain.
5. System b0,+: This transporter preferentially transports cationic amino acids such as lysine and arginine, but it can also transport some neutral amino acids. It is found in many tissues, including the intestines, kidneys, and brain.

These transport systems play important roles in maintaining amino acid homeostasis in the body, as well as in various physiological processes such as protein synthesis, neurotransmitter synthesis, and cell signaling. Dysregulation of these transport systems has been implicated in several diseases, including cancer, neurological disorders, and metabolic disorders.

Sodium-coupled vitamin C transporters, also known as SVCTs, are a type of membrane transport protein responsible for the active transport of vitamin C (ascorbic acid) into cells. There are two types of sodium-coupled vitamin C transporters, SVCT1 and SVCT2, which differ in their tissue distribution and function.

SVCT1 is primarily expressed in epithelial cells of the intestine and kidney, where it facilitates the absorption of vitamin C from food in the diet and reabsorption of vitamin C in the kidney. SVCT1 transports two sodium ions along with one molecule of vitamin C, using the energy generated by the sodium gradient to drive the uptake of vitamin C against its concentration gradient.

SVCT2, on the other hand, is widely expressed in various tissues, including the brain, eyes, and immune cells. It transports only one molecule of vitamin C at a time, without the need for sodium ions. SVCT2 plays a critical role in maintaining intracellular levels of vitamin C, particularly in tissues with high metabolic activity or high demand for vitamin C.

Overall, sodium-coupled vitamin C transporters are essential for the regulation of vitamin C homeostasis and play a crucial role in various physiological processes, including immune function, collagen synthesis, and antioxidant defense.

Organic anion transporters (OATs) are membrane transport proteins that facilitate the movement of organic anions across biological membranes. The term "sodium-dependent" refers to a specific type of OAT that requires sodium ions (Na+) as a co-transport substrate to move organic anions across the membrane. These transporters play crucial roles in the elimination and distribution of various endogenous and exogenous organic anions, including drugs, toxins, and metabolites. Sodium-dependent OATs are primarily located in the kidneys and liver, where they help maintain homeostasis by regulating the reabsorption and secretion of these substances.

Homeostasis is a fundamental concept in the field of medicine and physiology, referring to the body's ability to maintain a stable internal environment, despite changes in external conditions. It is the process by which biological systems regulate their internal environment to remain in a state of dynamic equilibrium. This is achieved through various feedback mechanisms that involve sensors, control centers, and effectors, working together to detect, interpret, and respond to disturbances in the system.

For example, the body maintains homeostasis through mechanisms such as temperature regulation (through sweating or shivering), fluid balance (through kidney function and thirst), and blood glucose levels (through insulin and glucagon secretion). When homeostasis is disrupted, it can lead to disease or dysfunction in the body.

In summary, homeostasis is the maintenance of a stable internal environment within biological systems, through various regulatory mechanisms that respond to changes in external conditions.

Glucose-6-phosphate (G6P) is a vital intermediate compound in the metabolism of glucose, which is a simple sugar that serves as a primary source of energy for living organisms. G6P plays a critical role in both glycolysis and gluconeogenesis pathways, contributing to the regulation of blood glucose levels and energy production within cells.

In biochemistry, glucose-6-phosphate is defined as:

A hexose sugar phosphate ester formed by the phosphorylation of glucose at the 6th carbon atom by ATP in a reaction catalyzed by the enzyme hexokinase or glucokinase. This reaction is the first step in both glycolysis and glucose storage (glycogen synthesis) processes, ensuring that glucose can be effectively utilized for energy production or stored for later use.

G6P serves as a crucial metabolic branch point, leading to various pathways such as:

1. Glycolysis: In the presence of sufficient ATP and NAD+ levels, G6P is further metabolized through glycolysis to generate pyruvate, which enters the citric acid cycle for additional energy production in the form of ATP, NADH, and FADH2.
2. Gluconeogenesis: During periods of low blood glucose levels, G6P can be synthesized back into glucose through the gluconeogenesis pathway, primarily occurring in the liver and kidneys. This process helps maintain stable blood glucose concentrations and provides energy to cells when dietary intake is insufficient.
3. Pentose phosphate pathway (PPP): A portion of G6P can be shunted into the PPP, an alternative metabolic route that generates NADPH, ribose-5-phosphate for nucleotide synthesis, and erythrose-4-phosphate for aromatic amino acid production. The PPP is essential in maintaining redox balance within cells and supporting biosynthetic processes.

Overall, glucose-6-phosphate plays a critical role as a central metabolic intermediate, connecting various pathways to regulate energy homeostasis, redox balance, and biosynthesis in response to cellular demands and environmental cues.

An oocyte, also known as an egg cell or female gamete, is a large specialized cell found in the ovary of female organisms. It contains half the number of chromosomes as a normal diploid cell, as it is the product of meiotic division. Oocytes are surrounded by follicle cells and are responsible for the production of female offspring upon fertilization with sperm. The term "oocyte" specifically refers to the immature egg cell before it reaches full maturity and is ready for fertilization, at which point it is referred to as an ovum or egg.

Glucagon is a hormone produced by the alpha cells of the pancreas. Its main function is to regulate glucose levels in the blood by stimulating the liver to convert stored glycogen into glucose, which can then be released into the bloodstream. This process helps to raise blood sugar levels when they are too low, such as during hypoglycemia.

Glucagon is a 29-amino acid polypeptide that is derived from the preproglucagon protein. It works by binding to glucagon receptors on liver cells, which triggers a series of intracellular signaling events that lead to the activation of enzymes involved in glycogen breakdown.

In addition to its role in glucose regulation, glucagon has also been shown to have other physiological effects, such as promoting lipolysis (the breakdown of fat) and inhibiting gastric acid secretion. Glucagon is often used clinically in the treatment of hypoglycemia, as well as in diagnostic tests to assess pancreatic function.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Northern blotting is a laboratory technique used in molecular biology to detect and analyze specific RNA molecules (such as mRNA) in a mixture of total RNA extracted from cells or tissues. This technique is called "Northern" blotting because it is analogous to the Southern blotting method, which is used for DNA detection.

The Northern blotting procedure involves several steps:

1. Electrophoresis: The total RNA mixture is first separated based on size by running it through an agarose gel using electrical current. This separates the RNA molecules according to their length, with smaller RNA fragments migrating faster than larger ones.

2. Transfer: After electrophoresis, the RNA bands are denatured (made single-stranded) and transferred from the gel onto a nitrocellulose or nylon membrane using a technique called capillary transfer or vacuum blotting. This step ensures that the order and relative positions of the RNA fragments are preserved on the membrane, similar to how they appear in the gel.

3. Cross-linking: The RNA is then chemically cross-linked to the membrane using UV light or heat treatment, which helps to immobilize the RNA onto the membrane and prevent it from washing off during subsequent steps.

4. Prehybridization: Before adding the labeled probe, the membrane is prehybridized in a solution containing blocking agents (such as salmon sperm DNA or yeast tRNA) to minimize non-specific binding of the probe to the membrane.

5. Hybridization: A labeled nucleic acid probe, specific to the RNA of interest, is added to the prehybridization solution and allowed to hybridize (form base pairs) with its complementary RNA sequence on the membrane. The probe can be either a DNA or an RNA molecule, and it is typically labeled with a radioactive isotope (such as ³²P) or a non-radioactive label (such as digoxigenin).

6. Washing: After hybridization, the membrane is washed to remove unbound probe and reduce background noise. The washing conditions (temperature, salt concentration, and detergent concentration) are optimized based on the stringency required for specific hybridization.

7. Detection: The presence of the labeled probe is then detected using an appropriate method, depending on the type of label used. For radioactive probes, this typically involves exposing the membrane to X-ray film or a phosphorimager screen and analyzing the resulting image. For non-radioactive probes, detection can be performed using colorimetric, chemiluminescent, or fluorescent methods.

8. Data analysis: The intensity of the signal is quantified and compared to controls (such as housekeeping genes) to determine the relative expression level of the RNA of interest. This information can be used for various purposes, such as identifying differentially expressed genes in response to a specific treatment or comparing gene expression levels across different samples or conditions.

Subcellular fractions refer to the separation and collection of specific parts or components of a cell, including organelles, membranes, and other structures, through various laboratory techniques such as centrifugation and ultracentrifugation. These fractions can be used in further biochemical and molecular analyses to study the structure, function, and interactions of individual cellular components. Examples of subcellular fractions include nuclear extracts, mitochondrial fractions, microsomal fractions (membrane vesicles), and cytosolic fractions (cytoplasmic extracts).

Learn about diagnosis and specialist referrals for Classic glucose transporter type 1 deficiency syndrome. ... Classic glucose transporter type 1 deficiency syndrome. Other Names: Classic GLUT1 deficiency syndrome; Classic GLUT1-DS; De ... Members of the medical team for Classic glucose transporter type 1 deficiency syndrome may include:. Primary care provider (PCP ... The type of lab tests ordered will depend on your symptoms and the diseases being considered.. Learn more about the type(s) of ...
... On-line free medical diagnosis assistant. Ranked list of possible diseases from either several ... Glucose transporter type 1. A ubiquitously expressed glucose transporter that is important for constitutive, basal glucose ... It is predominately expressed in endothelial cells and erythrocytes at the blood-brain barrier and is responsible for glucose ...
Knockout Tested Rabbit recombinant monoclonal Glucose Transporter GLUT1 antibody [EPR3915]. Validated in WB, IHC, ICC/IF, Flow ... Defects in SLC2A1 are the cause of glucose transporter type 1 deficiency syndrome (GLUT1DS) [MIM:606777]; also known as blood- ... HRP Anti-Glucose Transporter GLUT1 antibody [EPR3915] (ab195021) *Alexa Fluor® 488 Anti-Glucose Transporter GLUT1 antibody [ ... PE Anti-Glucose Transporter GLUT1 antibody [EPR3915] (ab209449) *Alexa Fluor® 405 Anti-Glucose Transporter GLUT1 antibody [ ...
Type 1 diabetes (T1D) is an autoimmune disease with a strong genetic component that has been associated with several genetic ... Glucose transporter 4 (GLUT4) is known to be an insulin-responsive glucose transporter and has been associated with various ... Interleukin-18 (rs187238) and glucose transporter 4 (rs5435) polymorphisms in Euro-Brazilians with type 1 diabetes. *Y. Al- ... of all human body glucose uptake mediated by glucose transporters (Malodobra-Mazur et al., 2016). A deficiency of the insulin- ...
... the protein that transports glucose across the blood brain barrier. Glucose Transporter Type 1 Deficiency Syndrome has an ... "Glucose Transporter Type 1 Deficiency Syndrome". GeneReviews.{{cite journal}}: CS1 maint: multiple names: authors list (link) ... "Glucose transporter type 1 deficiency syndrome , Genetic and Rare Diseases Information Center (GARD) - an NCATS Program". ... GLUT1 deficiency syndrome, also known as GLUT1-DS, De Vivo disease or Glucose transporter type 1 deficiency syndrome, is an ...
Glucose Transporter Type 1 / metabolism * Humans * Immunohistochemistry * Intracellular Signaling Peptides and Proteins / ... Marianna Grinberg 1 , Dijana Djureinovic 2 , Hans Rr Brunnström 3 , Johanna Sm Mattsson 2 , Karolina Edlund 4 , Jan G Hengstler ... 1 Department of Statistics, TU Dortmund University, Dortmund, Germany.. *2 Department of Immunology, Genetics and Pathology, ... The five selected proteins (MKI67, EZH2, SLC2A1, CADM1, and NKX2-1 alias TTF1) were analyzed by immunohistochemistry on tissue ...
Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities ... Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities ...
Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep. 2013 Apr;13(4):342 ... Wang D, Pascual JM, De Vivo D. Glucose Transporter Type 1 Deficiency Syndrome. 2002 Jul 30 [updated 2018 Mar 1]. In: Adam MP, ... This gene provides instructions for producing a protein called the glucose transporter protein type 1 (GLUT1). The GLUT1 ... Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 2010 Mar ...
Keywords: children; drug-resistant epilepsy; e-mail; glucose transporter type 1 deficiency syndrome; home management; ketogenic ... or glucose transporter type 1 deficiency syndrome (GLUT1-DS; n = 20). All the e-mails were evaluated analyzing their frequency ... Cinzia Ferraris 1 , Monica Guglielmetti 1 , Elisa Tamagni 1 , Claudia Trentani 1 , Valentina De Giorgis 2 , Ludovica Pasca 2 , ... 1 Human Nutrition and Eating Disorder Research Center, Department of Public Health, Experimental and Forensic Medicine, ...
Milder phenotypes of glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol 2011; 53: 664-668 ... Within the main glucose transporter families, glucose transporter 1 (GLUT1) and its corresponding gene SLC2A were identified in ... Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro . ... Glucose is the main energy source of the brain and crosses the blood-brain barrier through glucose transporter proteins [1]. ...
It often takes years, however, before those suffering from the rare glucose transporter type 1 (Glut1) deficiency syndrome ... They cause the Glut1 protein to lose its function in the cell membrane: the protein no longer transports glucose from the blood ... the Glut1 protein found its way back to the cell surface and resumed glucose uptake. "This could theoretically be blocked by ... where it takes up glucose. The protein was instead in the cells interior as if it had gotten lost. ...
Histochemical analysis of glucose transporter type 1 expression in mouse uterine natural killer cells. Kyi-Tha-Thu C, Takizawa ... Penile metastasis secondary to nasal-type extranodal natural killer/T-cell lymphoma: A case report and review of the literature ... 2016 pp: 1-17. Role of RhoA/MERK1/ERK1/2/iNOS signaling in ocular ischemic syndrome. Du R, Wang J, Wang Y. Graefes Archive for ... 2016 pp: 1-10. Lacrimal Gland Repair Using Progenitor Cells. Gromova A, Voronov D, Yoshida M, Thotakura S, Meech R, et. al.. ...
Glucose Transporter Type 1/genetics. MESH. Humans. MESH. Hypoxia-Inducible Factor 1, alpha Subunit/metabolism. MESH. ... The glucose transporter isoform 1 (GLUT1) gene encodes a key rate-limiting factor in glucose transport into cancer cells. ... The glucose transporter isoform 1 (GLUT1) gene encodes a key rate-limiting factor in glucose transport into cancer cells. ... Furthermore, inhibition of GLUT1 expression reduced both glucose uptake and lactate secretion. Hypoxic conditions further ...
... uptake of glucose by astrocytes from the bloodstream via glucose transporter type 1 (GLUT1) couples with the uptake of ... Astrocytic equilibrative nucleoside transporter type 1 upregulations in the dorsomedial and dorsolateral striatum distinctly ... the glucose is converted to lactate which can be transferred by monocarboxylate transporters (MCT) from astrocytes to neurons [ ... Three crucial transporters or receptors are responsible for the astrocytic and synaptic glutamate release and elimination. They ...
Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514, 181-186 (2014). This study ... Tao, Y.-W., Gu, Y.-L., Mao, X.-Q., Zhang, L. & Pei, Y.-F. Effects of probiotics on type II diabetes mellitus: a meta-analysis. ... Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262-266 (2015). ... Roux-Y gastric bypass and sleeve gastrectomy directly change gut microbiota composition independent of surgery type. Sci. Rep. ...
... such ascorbate transport appeared to be independent of the glucose transporter, in that glucose did not compete for such ... Herpes simplex virus type-1 (HSV) amplicon vectors containing neuroprotective genes can alter cell physiology and enhance ... vectors overexpressing the rat brain glucose transporter (GT) gene (gt) can enhance glucose uptake in adult rat hippocampus and ... Overexpression of the glucose transporter gene with a Herpes simplex viral vector protects striatal neurons against stroke ...
... oral dual inhibitor of two proteins responsible for glucose regulation known as sodium-dependent glucose co-transporter types 1 ... The approval is for adjunct use to insulin therapy to improve blood sugar (glycemic) control in adults with type I diabetes ... "For the many people living with type I diabetes who are overweight or obese, Zynquista will offer a new treatment option ... "Millions of people across Europe who live with type I diabetes struggle to control their blood sugar, even with optimal insulin ...
Classic Glucose Transporter Type 1 Deficiency Syndrome. Ataxia, Paralysis, Chorea, Choreoathetosis, Seizure, Hemiparesis, ... The IMPC applies a panel of phenotyping screens to characterise single-gene knockout mice by comparison to wild types. Click on ... Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration And Progressive Polyneuropathy Type). ...
First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome Angeli ... The Effect of Y Content on Structural and Sorption Properties of A2B7-Type Phase in the La-Y-Ni-Al-Mn System Jensen E.H., ... Ultrasensitive Self-Driven Terahertz Photodetectors Based on Low-Energy Type-II Dirac Fermions and Related Van der Waals ... Crystal structure of an L-type lectin domain from archaea Khan Farha, Kaza Suguna Proteins: Structure, Function and ...
Combination of triheptanoin with the ketogenic diet in Glucose transporter type 1 deficiency (G1D). Avila, A., Málaga, I., ... Chang, W., Zhao, Y., Rayêe, D., Xie, Q., Suzuki, M., Zheng, D. & Cvekl, A., Dec 2023, In: Epigenetics and Chromatin. 16, 1, 4. ... Ji, L., Zhaoyang, R., Jiao, J. L., Schade, M. M., Bertisch, S., Derby, C. A., Buxton, O. M. & Gamaldo, A. A., Apr 1 2023, In: ... Blumen, H. M., Jayakody, O. & Verghese, J., Jan 2023, In: International Journal of Stroke. 18, 1, p. 53-61 9 p.. Research ...
Glucose Transporter Type 1 Deficiency Syndrome very common attribute of kind 2 diabetes in sufferers who Fasting Blood Sugar ... Anyhow, You need to buy the glucose Type 2 diabetes sudden low blood sugar strips separately at the nearby Fasting Blood Sugar ... Simply put glucose can Blood sugar insulin calculator exist Fasting Blood Sugar Too High Gestational Diabetes in two forms that ... Your liver can also make its own glucose using a combination Low fasting blood sugar in children of waste products, amino acids ...
... glucose transporter type 1 (GLUT1) deficiency syndrome, and exercise performance.. The cancer study, funded by a charitable ... Therapeutic ketosis causes the body to shift from using glucose to fatty acids and ketones bodies for energy. ... Written by · June 10, 2015 @ 1:54 pm · Filed under Hot News, Morsani College of Medicine, News Releases, Research ...
... discusses treating type 2 diabetes early and using drugs to correct the pathophysiologic disturbances associated with it. ... the sodium-glucose co-transporter 2 (SGLT2) inhibitors, and pioglitazone. Those are the three drugs that I use in combination ... One of the major problems we have to deal with in terms of the treatment of type 2 diabetes is to recognize that its a very ... Early treatment of type 2 diabetes is essential because we have an impairment in beta-cell function when you first see the ...
These enzymes normally catalyze reactions that ultimately convert glycogen compounds to glucose. ... type Ia and type Ib. GSD type Ib is caused by a mutation in the glucose-6-phosphate transporter gene (G6PT1, also known as ... GSD type Ia, glucose-6-phosphatase deficiency or type Ib, glucose-6-phosphate transporter mutation). The remaining GSDs are not ... GSD type Ib is an autosomal recessive condition caused by a mutation in the glucose-6-phosphate transporter gene (G6PT1, also ...
Glucose transporter type 1 deficiency syndrome effectively treated with modified atkins diet. ...
20403-1-AP. Tested in Western Blot (WB) and Immunohistochemistry (Paraffin) (IHC (P)) applications. This antibody reacts with ... glucose transporter 3; Glucose transporter type 3, brain; GLUT-3; solute carrier family 2 (facilitated glucose transporter), ... glucose transmembrane transporter activity glucose binding dehydroascorbic acid transporter activity D-glucose transmembrane ... neuron glucose transporter); Solute carrier family 2, facilitated glucose transporter member 3; solute carrier family 2, member ...
In hypoxic intestinal cells, fructose 1-phosphate inhibits the M2 isoform of pyruvate kinase to promote cell survival5-7. ... and phosphorylated by ketohexokinase to form fructose 1-phosphate, which accumulates to high levels in the cell3,4. Although ... where fructose is transported by glucose transporter type 5 (GLUT5; encoded by SLC2A5) ... where fructose is transported by glucose transporter type 5 (GLUT5; encoded by SLC2A5) and phosphorylated by ketohexokinase to ...
  • GLUT1 deficiency syndrome, also known as GLUT1-DS, De Vivo disease or Glucose transporter type 1 deficiency syndrome, is an autosomal dominant genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier. (wikipedia.org)
  • Glucose Transporter Type 1 Deficiency Syndrome has an estimated birth incidence of 1 in 90,000 to 1 in 24,300. (wikipedia.org)
  • It is estimated that 10% of individuals with Glut 1 Deficiency do not have seizures and symptoms are typically less severe in these cases. (wikipedia.org)
  • The frequency, severity and types of seizures may vary considerably among GLUT1 deficiency patients and do not necessarily correspond to the severity of other symptoms. (wikipedia.org)
  • 1 Brockmann K. The expanding phenotype of Glut 1-deficiency syndrome. (thieme-connect.com)
  • 7 Klepper J, Voit T. Facilitated glucose transporter protein type 1 (Glut 1) deficiency syndrome: impaired glucose transporter into brain - a review. (thieme-connect.com)
  • It often takes years, however, before those suffering from the rare glucose transporter type 1 (Glut1) deficiency syndrome obtain a correct diagnosis. (eurekalert.org)
  • The USF team believes these novel ketone supplements may be effective in other disorders besides cancer and have ongoing studies to test their potential use in wound healing, epilepsy, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, glucose transporter type 1 (GLUT1) deficiency syndrome, and exercise performance. (usf.edu)
  • Although 4 other cases were reported of excess glycogen storage in the livers of autopsy patients, it was not until 1978 when Narisawa et al were able to differentiate GSD type Ia and type Ib, recognizing type Ia was due to a deficiency in the G6Pase enzyme, and type Ib was due to deficiency in the G6P transporter. (medscape.com)
  • Glucose transporter type 1 deficiency syndrome effectively treated with modified atkins diet. (atkins-hcp.com)
  • Several naturally occurring, pathogenic mutations that cause GLUT1 deficiency syndrome disrupt this PKC phosphomotif, impair the phosphorylation of S226 in vitro, and block TPA-mediated increases in glucose uptake. (elsevierpure.com)
  • The increase in total operating expenses is due to the initiation of new programs for glucose transporter type-1 deficiency syndrome (Glut1 DS) and X-linked hypophosphatemia, as well as the initiation of the Phase 2 clinical study of triheptanoin in fatty acid oxidation disorders (FAOD), higher general and administrative costs related to being a public company, and increased headcount. (healthcap.eu)
  • Objective To expand the spectrum of glucose transporter type 1 deficiency syndromes with a novel clinical and radiological phenotype not associated with microcephaly. (jamanetwork.com)
  • The genetic disorder glucose transporter type 1 deficiency syndrome can also cause absence seizures. (epilepsyu.com)
  • Although at least 14 unique GSDs are discussed in the literature, the 4 that cause clinically significant muscle weakness are Pompe disease ( GSD type II , acid maltase deficiency), Cori disease ( GSD type III , debranching enzyme deficiency), McArdle disease ( GSD type V , myophosphorylase deficiency), and Tarui disease ( GSD type VII , phosphofructokinase deficiency). (medscape.com)
  • One form, Von Gierke disease ( GSD type Ia , glucose-6-phosphatase deficiency ), causes clinically significant end-organ disease with significant morbidity. (medscape.com)
  • Glucose-6-phosphatase (G-6-P) is the specific enzyme deficiency in Von Gierke disease. (medscape.com)
  • Erythrocyte 3-O-methyl-D-glucose uptake essay for diagnosis of glucose-transporter-protein syndrome. (thieme-connect.com)
  • Niemann-Pick type C is an uncommon neurodegenerative lysosomal storage disorder that can cause a progressive neuropsychiatric syndrome associated with supranuclear vertical gaze palsy and a movement disorder. (bmj.com)
  • At the top of the list, I would put the glucagon-like peptide 1 (GLP-1) receptor agonists, the sodium-glucose co-transporter 2 (SGLT2) inhibitors, and pioglitazone . (medscape.com)
  • Now we have strong data with GLP-1 receptor agonists, SGLT2 inhibitors, and pioglitazone that they are cardioprotective. (medscape.com)
  • From the standpoint of renal disease, we also now have very strong data with the SGLT2 inhibitors, emerging data from the GLP-1 receptor agonists, and a new class of drugs that don't lower glucose, but finerenone, which is effective in providing protection against cardiovascular disease and renal disease. (medscape.com)
  • Objective To review the security and effectiveness from the dipeptidylpeptidase-4 (DPP-4) inhibitors in individuals with type 2 diabetes and inadequate glycemic control. (exposed-skin-care.net)
  • Conclusions This organized evaluate and MTC demonstrated similar effectiveness and security for DPP-4 inhibitors as treatment for type 2 diabetes, either as monotherapy or mixture therapy. (exposed-skin-care.net)
  • Systematic Books Search We carried out a organized review of released literature to measure the comparative effectiveness and security of DPP-4 inhibitors in comparison to additional dental and injectable anti-diabetic pharmacologic interventions, including insulin, in the treating individuals with type 2 diabetes who have been getting monotherapy, dual, or triple therapy. (exposed-skin-care.net)
  • Treatment: any DPP-4 inhibitor (alogliptin, linagliptin, saxagliptin, sitagliptin, and vildagliptin), GLP-1 or sodium-glucose co-transporter 2 inhibitors, or pioglitazone found in the treating Bosutinib type 2 diabetes (as monotherapy, dual or triple therapy). (exposed-skin-care.net)
  • SGLT2 inhibitors represent a novel class of oral glucose- lowering treatment that addresses some important unmet clinical needs in the treatment of type 2 diabetes, specifically weight reduction and a low propensity to cause hypoglycaemia. (bjd-abcd.com)
  • Specifically, we will quantify population-level use of two classes of glucose-lowering agents: Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1A). (edu.au)
  • Recently, along with increasing use of immune checkpoint inhibitors such as nivolumab, the incidence of immune-related adverse events, including type 1 diabetes mellitus, has become a serious problem. (cdc.gov)
  • Immune checkpoint inhibitors (ICIs), including nivolumab, target programmed cell death protein-1 and have been used to treat malignancies, including melanoma, nonsmall cell lung cancer, and renal cell carcinoma. (cdc.gov)
  • Clinical course after immune checkpoint inhibitors treatment initiation for type 1 diabetes mellitus associated with nivolumab after second SARS-CoV-2 vaccination, Japan. (cdc.gov)
  • glucosidase inhibitors, glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-IV inhibitors, sodium glucose co-transporter 2 inhibitors, bromocriptine, and bile acid sequestrants. (cdc.gov)
  • But if I have a choice, I find drugs that can help with weight loss, and that includes G LP -1 receptor agonists and SGLT2 inhibitors. (medscape.com)
  • We discuss the unfortunate lack of data that we have on the combination of SGLT2 inhibitors and GLP-1 receptor agonists. (medscape.com)
  • HA565 trade name] is indicated as a pharmacokinetic enhancer for protease inhibitors when these are used in combination therapy with other antiretroviral agents for the treatment of HIV-1 infected patients. (who.int)
  • The following HIV-1 protease inhibitors can be used with ritonavir as a pharmacokinetic enhancer at the noted doses. (who.int)
  • The rapid eye movements that some Glut 1 patients exhibit are rapid, multidirectional, and there is often a head movement in the same direction as the eye movement. (wikipedia.org)
  • Several glucose transporter protein (Glut) isoforms have been identified and shown to function in response to insulin and IGF1 induced signaling. (thermofisher.com)
  • Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients. (edu.pl)
  • Meyer was able to confirm her hypothesis: When she blocked this process, the Glut1 protein found its way back to the cell surface and resumed glucose uptake. (eurekalert.org)
  • Furthermore, inhibition of GLUT1 expression reduced both glucose uptake and lactate secretion. (uni-regensburg.de)
  • Phosphorylation of S226 is required for the rapid increase in glucose uptake and enhanced cell surface localization of GLUT1 induced by the phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA). (elsevierpure.com)
  • Our goal is to increase the uptake of SGLT2i and GLP-1A among people with type 2 diabetes. (edu.au)
  • While this research is on uptake of SGLT2is and GLP-1a for treatment of diabetes, we will also create a framework for assessing the diffusion of therapies for other clinical populations, such as expansions in use of SGLT2is for conditions beyond type 2 diabetes (e.g. heart failure, chronic kidney disease). (edu.au)
  • Glucose is fundamental to the metabolism of mammalian cells. (thermofisher.com)
  • Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. (rush.edu)
  • Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice. (rush.edu)
  • The endocannabinoid system affects myocardial glucose metabolism in the DOCA-salt model of hypertension. (edu.pl)
  • Elisabeth Björk, Senior Vice President, Head of late Cardiovascular, Renal and Metabolism, R&D BioPharmaceuticals, said: "This approval of Forxiga in Japan means that people with type-1 diabetes whose glucose levels are not adequately controlled with insulin alone now have a new oral treatment option available to them. (worldpharmanews.com)
  • Glucose-6-phosphate is an intermediate in glycogen synthesis and glucose metabolism. (medscape.com)
  • The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. (medscape.com)
  • Veiga-da-Cuhna and colleagues provide evidence that all non-1a cases can be explained by mutations of the glucose-6-phosphate translocase gene. (medscape.com)
  • A biomarker panel was selected based on (1) prognostic association in published literature, (2) prognostic association in gene expression data sets, (3) availability of reliable antibodies, and (4) representation of diverse biological processes. (nih.gov)
  • This gene provides instructions for producing a protein called the glucose transporter protein type 1 (GLUT1). (medlineplus.gov)
  • Within the main glucose transporter families, glucose transporter 1 (GLUT1) and its corresponding gene SLC2A were identified in 1985 [ 2 ]. (thieme-connect.com)
  • The glucose transporter isoform 1 (GLUT1) gene encodes a key rate-limiting factor in glucose transport into cancer cells. (uni-regensburg.de)
  • The IMPC applies a panel of phenotyping screens to characterise single-gene knockout mice by comparison to wild types. (mousephenotype.org)
  • 3. Kitamura R, Ishii K, Maeda I, Kozaki T, Iwabuchi K, Saito T, Evaluation of bacterial communities by bacteriome analysis targeting 16S rRNA genes and quantitative analysis of ammonia monooxygenase gene in different types of compost. (webmedcentral.com)
  • Type 1 results from mutations in the integrin beta-2 gene ( ITGB2 ), encoding CD18 beta-2 integrins. (msdmanuals.com)
  • Type 2 results from mutations in the glucose diphosphate (GDP)-fucose transporter gene. (msdmanuals.com)
  • Type 3 is caused by mutations in the FERMT3 gene (11q13.1), which encodes kindlin-3 in hematopoietic cells. (msdmanuals.com)
  • Correction of glycogen storage disease type 1a in a mouse model by gene therapy. (medscape.com)
  • Gene therapy for type I glycogen storage diseases. (medscape.com)
  • GSD type Ib differs from GSD type Ia in that it is not explained by mutations of the phosphohydrolase gene. (medscape.com)
  • Type 1 diabetes (T1D) is an autoimmune disease with a strong genetic component that has been associated with several genetic loci. (geneticsmr.org)
  • Glucose transporter 4 (GLUT4) is known to be an insulin-responsive glucose transporter and has been associated with various diseases, including diabetes mellitus. (geneticsmr.org)
  • Type 1 diabetes (T1D) is characterized by T cell-mediated destruction of insulin-producing pancreatic beta cells. (geneticsmr.org)
  • Sanofi has announced that its joint SGLT1/SGLT2 inhibitor with Lexicon, Zynquista (sotagliflozin), has been approved in Europe for certain patients with type I diabetes. (pharmatimes.com)
  • The approval is for adjunct use to insulin therapy to improve blood sugar (glycemic) control in adults with type I diabetes mellitus and a body mass index of 27 kg/m2 or more, who could not achieve adequate glycemic control despite optimal insulin therapy. (pharmatimes.com)
  • Millions of people across Europe who live with type I diabetes struggle to control their blood sugar, even with optimal insulin therapy," commented Thomas Danne, Professor of Pediatrics, Children's Hospital 'Auf der Bult,' Hannover, Germany. (pharmatimes.com)
  • For the many people living with type I diabetes who are overweight or obese, Zynquista will offer a new treatment option physicians can now consider in combination with insulin therapy for appropriate patients. (pharmatimes.com)
  • Gluconeogenesis and Fasting Blood Sugar Too High Gestational Diabetes glycogenolysis are important for maintenance of the plasma glucose concentration. (2mtravel.ba)
  • Talk to your physician about methods to quit smoking or to stop using other kinds of tobacco Get a flu shot every year, and your doctor may suggest the pneumonia vaccine, as nicely In some individuals who have type 1 diabetes, a pancreas transplant could additionally be an option With a successful pancreas transplant, you ll now not need insulin remedy People with sort 1 diabetes want insulin remedy to survive. (2mtravel.ba)
  • Simply put glucose can Blood sugar insulin calculator exist Fasting Blood Sugar Too High Gestational Diabetes in two forms that are What Is Normal Blood Sugar mirror images of each other. (2mtravel.ba)
  • Anyhow, You need to buy the glucose Type 2 diabetes sudden low blood sugar strips separately at the nearby Fasting Blood Sugar Too High Gestational Diabetes drug store. (2mtravel.ba)
  • Early treatment of type 2 diabetes is essential because we have an impairment in beta-cell function when you first see the diabetic patient, and what's causing that progressive rise in A1c is progressive beta-cell failure. (medscape.com)
  • We've also learned from the Diabetes Control and Complications Trial (DCCT) in patients with type 1 diabetes and from the United Kingdom Prospective Diabetes Study (UKPDS) in patients with type 2 diabetes that if you start early, on a long-term basis, you're going to be in better shape in preventing both the micro- and macrovascular complications. (medscape.com)
  • Eligibility requirements Individuals with type 2 diabetes and insufficient glycemic control getting any pharmacological anti-diabetic treatment. (exposed-skin-care.net)
  • pharmacologic therapies for type 2 diabetes. (exposed-skin-care.net)
  • studies conference these criteria had been regarded as for inclusion: Populace: individuals of any age group or sex with type 2 diabetes and inadequate glycemic control (including 1st-, second-, and third-line treatment regimens). (exposed-skin-care.net)
  • The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Forxiga (dapagliflozin) as an oral adjunct treatment to insulin for adults with type-1 diabetes (T1D). (worldpharmanews.com)
  • Forxiga will help address a significant unmet need in this patient population, and this approval in type-1 diabetes builds on the well-established clinical profile of Forxiga. (worldpharmanews.com)
  • The safety profile of Forxiga in these T1D trials was consistent with its well-established profile in type-2 diabetes (T2D), with the exception of a higher number of diabetic ketoacidosis (DKA) events in Forxiga-treated patients versus placebo. (worldpharmanews.com)
  • Approximately five percent of people living with diabetes have type-1. (worldpharmanews.com)
  • 4) Different factors, including genetics and some viruses, may contribute to type-1 diabetes. (worldpharmanews.com)
  • The DEPICT (Dapagliflozin Evaluation in Patients with Inadequately Controlled Type 1 Diabetes) clinical trial programme consists of two trials: DEPICT-1 and DEPICT-2 which are 24-week, randomised, double-blinded, parallel-controlled trials designed to assess the effects of Forxiga 5mg or 10mg on glycaemic control in patients with T1D inadequately controlled by insulin. (worldpharmanews.com)
  • Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24-week results from a randomised controlled trial. (worldpharmanews.com)
  • There have been reports of several cases of ketoacidosis, mostly euglycaemic, and in people with type 1 or type 2 diabetes. (bjd-abcd.com)
  • Dapagliflozin in combination therapy for treating type 2 diabetes. (bjd-abcd.com)
  • Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. (bjd-abcd.com)
  • Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. (bjd-abcd.com)
  • Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration. (bjd-abcd.com)
  • Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial. (bjd-abcd.com)
  • Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. (bjd-abcd.com)
  • We sought to examine the role of both urinary and circulating TGF-β1 and its promoter Amadori albumin in the vascular complications of type 1 diabetes. (diabetesjournals.org)
  • RESEARCH DESIGN AND METHODS -The present article reports on a nested case-control study from the EURODIAB Prospective Complications Study of Europeans with type 1 diabetes. (diabetesjournals.org)
  • Improvements in glycemic control and the greater use of antihypertensive therapy should eventually have a beneficial impact on the incidence of severe nephropathy in type 1 diabetes. (diabetesjournals.org)
  • can a virus infection affexct blood sugar What Is Type 2 Diabetes Normal Blood Sugar does high blood sugar cause excessive sweating Fakultas Ilmu Kesehatan. (esaunggul.ac.id)
  • Our research will create an 'atlas' of best-practice medicine use for treatment of type 2 diabetes across New South Wales. (edu.au)
  • We will map out how these are being used relative to the prevalence of type 2 diabetes and estimated need. (edu.au)
  • While both medicine classes are subsidised by the Australian Government, we estimate less than a quarter of people living with type 2 diabetes are using these highly effective and potentially life-saving medicines. (edu.au)
  • We report a patient who had immune checkpoint inhibitor‒associated type 1 diabetes mellitus that developed after a second mRNA-based SARS-CoV-2 vaccination. (cdc.gov)
  • The aim of the study was to describe recent medication patterns and changes in medication patterns and glycemic control in adolescents and young adults with incident type 2 diabetes (T2D). (cdc.gov)
  • Today I am going to discuss the 2015 update to the position statement on the treatment of hyperglycemia in patients with type 2 diabetes . (medscape.com)
  • [ 2 ] I was hoping at some point in this process that we would come up with a simple algorithm for treating type 2 diabetes, an algorithm everyone can follow in every practice setting. (medscape.com)
  • I hope these guidelines are useful to you in your practice and make it easier for you to choose among the various medications we have for treating patients with type 2 diabetes, and for helping them successfully achieve their targets. (medscape.com)
  • Here, discover the type of medical professionals that can help, tools for finding them, and tips for getting the most out of your care as you navigate to a diagnosis. (nih.gov)
  • Forxiga (dapagliflozin) is a first-in-class, oral once-daily selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2) indicated as both monotherapy and as part of combination therapy to improve glycaemic control, with the additional benefits of weight loss and blood pressure reduction, as an adjunct to diet and exercise in adults with T2D. (worldpharmanews.com)
  • It is at that level that these guidelines are a bit different, [ 1 ] because we now include the sodium-glucose co-transporter 2 (SGLT2) inhibitor class at that step. (medscape.com)
  • We discuss using the combination of basal insulin plus a glucagon -like peptide-1 (GLP-1) receptor agonist and, potentially, also the combination of insulin plus an SGLT2 inhibitor. (medscape.com)
  • Your liver can also make its own glucose using a combination Low fasting blood sugar in children of waste products, amino acids, and fats. (2mtravel.ba)
  • Although there is no cure, a diet that avoids fasting to maintain normal glucose level is the mainstay of life-long treatment. (medscape.com)
  • Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-related neurons in the arcuate nucleus. (rush.edu)
  • Fasting plasma glucose level was 94 mg/dL and glycated hemoglobin (HbA1c) 5.6% at treatment initiation. (cdc.gov)
  • Hormonal regulation of malic enzyme and glucose-6-phosphate dehydrogenase in brown adipose tissue. (rush.edu)
  • In glycogen storage disease type I, the enzyme glucose-6-phosphatase is defective in the liver, kidney, and small intestine, where it normally functions. (lu.se)
  • GSD type I, also known as Von Gierke disease, is an autosomal recessive disorder, divided into two subtypes: type Ia and type Ib. (medscape.com)
  • Glycogen storage diseases ( GSD ) are a group of inherited autosomal recessive disorders caused by genetic mutations that lead to the inability to breakdown and metabolize glycogen into glucose. (medscape.com)
  • GSD type Ib is an autosomal recessive condition. (medscape.com)
  • The five selected proteins (MKI67, EZH2, SLC2A1, CADM1, and NKX2-1 alias TTF1) were analyzed by immunohistochemistry on tissue microarrays including tissue from 326 non-small cell lung cancer patients. (nih.gov)
  • Glucose is the main energy source of the brain and crosses the blood-brain barrier through glucose transporter proteins [ 1 ]. (thieme-connect.com)
  • Zynquista is an oral dual inhibitor of two proteins responsible for glucose regulation known as sodium-dependent glucose co-transporter types 1 and 2, which are responsible for glucose absorption in the gastrointestinal tract, and glucose reabsorption by the kidney, respectively. (pharmatimes.com)
  • St Hilaire R, Costello H. Prescriber beware: report of adverse effect of sodium-glucose cotransporter 2 inhibitor use in a patient with contraindication. (bjd-abcd.com)
  • Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet. (bjd-abcd.com)
  • Results showed that Forxiga, when given as an oral treatment in addition to adjustable insulin in patients with inadequately-controlled T1D, demonstrated significant and clinically-meaningful reductions from baseline in average blood glucose levels HbA1c (primary endpoint), weight and total daily insulin dose (secondary endpoints) at 24 weeks(1,2,3), at both 5mg and 10mg doses. (worldpharmanews.com)
  • Blood glucose decreased in response to continuous intravenous administration of insulin and saline. (cdc.gov)
  • The patient's blood glucose level was ultimately controlled by intensive insulin therapy (degludec 9 U before dinner and lispro 24 U before breakfast, 5 U before lunch, and 15 U before dinner). (cdc.gov)
  • Plasma glucose and HbA1c were tested every 4 weeks. (cdc.gov)
  • His range of plasma glucose was 90-123 mg/dL and that of HbA1c was 5.4%-5.7% ( Figure ). (cdc.gov)
  • [ 1 ] leading to a defect in the last step of glycogenolysis, resulting in fat accumulation and dysfunction of the liver and kidneys, infantile hypoglycemia, hepatomegaly, and life-threatening seizures if not treated early. (medscape.com)
  • Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. (rush.edu)
  • The G-6-P transporter protein is found in the liver and kidney. (medscape.com)
  • The following product was used in this experiment: GLUT3 Polyclonal Antibody from Thermo Fisher Scientific, catalog # 20403-1-AP. (thermofisher.com)
  • This antibody was generated against the internal region of human GLUT3 and may cross-react with GLUT14.20403-1-AP antibody detects the bands around 48-60 kDa in SDS-PAGE. (thermofisher.com)
  • These changes were present in both severe and mild AE but were much stronger in people with LGI-1 antibody associated AE. (autoimmune-encephalitis.org)
  • Das AM, Lücke T, Meyer U, Hartmann H, Illsinger S. Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth. (medscape.com)
  • Structure-function study of the glucose-6-phosphate transporter, an eukaryotic antiporter deficient in glycogen storage disease type Ib. (medscape.com)
  • Vitamin E supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b. (medscape.com)
  • D'Eufemia P, Finocchiaro R, Celli M, Zambrano A, Tetti M, Ferrucci V. Absence of severe recurrent infections in glycogen storage disease type Ib with neutropenia and neutrophil dysfunction. (medscape.com)
  • Schwahn B, Rauch F, Wendel U, Schönau E. Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control. (medscape.com)
  • Bone marrow transplantation in glycogen storage disease type 1b. (medscape.com)
  • Bijvoet AG, Van Hirtum H, Vermey M. Pathological features of glycogen storage disease type II highlighted in the knockout mouse model. (medscape.com)
  • GLUT3 is detectable in a few normal cell type spermatids in testis with active spermatogenesis, placental trophoblast membranes, and neurons in brain. (thermofisher.com)
  • Oculomotor involvement is described in both phenotypes and includes eye rolling, horizontal roving eye movements, and head bobbing [ 1 ]. (thieme-connect.com)
  • Interestingly, there also is a GSD type 0, which is due to defective glycogen synthase. (medscape.com)
  • Mice lacking brain-type creatine kinase activity show defective thermoregulation. (rush.edu)
  • GSD type 1b is a similar condition with a defective G-6-P transporter protein. (medscape.com)
  • Fig. 1: Dietary fructose increases intestinal villus length and lipid absorption. (nature.com)
  • However, early disease, such as microalbuminuria and macroalbuminuria, will continue to occur because glycemic control cannot wholly prevent the progression of albuminuria, and there is currently little evidence that antihypertensive use in normotensive normoalbuminuric patients is of clinical value ( 1 ). (diabetesjournals.org)
  • Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. (bjd-abcd.com)
  • Physicians now recognize that zinc supplementation can reduce the incidence and severity of diarrheal disease, and an ORS of reduced osmolarity (i.e., proportionally reduced concentrations of sodium and glucose) has been developed for global use. (cdc.gov)
  • We demonstrate that the phosphorylation of GLUT1 on S226 regulates glucose transport and propose that this modification is important in the physiological regulation of glucose transport. (elsevierpure.com)
  • KetoCal® 4:1 liquid (LQ) Chocolate is a ketogenic formula with a 4:1 ratio (fat:carbohydrate + protein). (myketocal.com)
  • It is predominately expressed in endothelial cells and erythrocytes at the blood-brain barrier and is responsible for glucose entry into the BRAIN. (lookfordiagnosis.com)
  • where it transports a simple sugar called glucose into cells from the blood or from other cells for use as fuel. (medlineplus.gov)
  • In the brain, the GLUT1 protein is involved in moving glucose, which is the brain's main energy source, across the blood-brain barrier. (medlineplus.gov)
  • They cause the Glut1 protein to lose its function in the cell membrane: the protein no longer transports glucose from the blood into the brain. (eurekalert.org)
  • Glucose Fakultas Ilmu Kesehatan does high blood sugar cause excessive sweating needs to be in your blood, and a healthy balance of it in your body is indeed as delightful as wine to those ancient Greeks. (esaunggul.ac.id)
  • When does high blood sugar cause excessive sweating living cells are used to catalyze the oxidation of glucose, the device is referred to as a microbial fuel cell. (esaunggul.ac.id)
  • This does high blood sugar cause excessive sweating does high blood sugar cause excessive sweating involvesusing facilitative diffusion to carry glucose down a concentration gradient, into Fakultas Ilmu Kesehatan does high blood sugar cause excessive sweating the cell. (esaunggul.ac.id)
  • Once measure blood sugar au quebec the glucose has entered the cell, the cell works to burn the glucose to create energy. (esaunggul.ac.id)
  • The tissue was also metabolically active, as it actively took up glucose upon stimulation, and hcpcs elevated blood sugar level mice receiving this tissue had a significant improvement does high blood sugar cause excessive sweating does high blood sugar cause excessive sweating in cold tolerance. (esaunggul.ac.id)
  • NB In this example Area B Fakultas Ilmu Kesehatan does high blood sugar cause excessive sweating is a negative value, as does high blood sugar cause excessive sweating glucose concentrations have dropped to lower than the initial fasted value. (esaunggul.ac.id)
  • Cardiovascular risk factors, including hypertension, hyperlipidaemia, obesity and smoking, were studied as well as degree of blood glucose control. (who.int)
  • We aim in our work to study the prevalence risk factors and degree of blood glucose of CVD risk factors in diabetics in two dif- control. (who.int)
  • I like that combination because it uses drugs that are great at lowering blood glucose levels, that help with weight loss, and that don't cause hypoglycemia. (medscape.com)
  • 1) Adrenergic receptor is key to cold- and diet-induced thermogenesis in mice. (rush.edu)
  • Inactivation of the adrenergic receptor ?2 disrupts glucose homeostasis in mice. (rush.edu)
  • Slc41a1-/- mice exhibited similar serum and urine Mg2+ levels as their wild-type littermates. (bvsalud.org)
  • Although Slc41a3-/- knockout mice showed significantly reduced serum Mg2+ compared with wild-type and Slc41a1-/- knockout groups, double knockout mice displayed similar serum Mg2+ levels as Slc41a3-/- knockout mice. (bvsalud.org)
  • The effect of Mg2+ was not modulated by 1,25D, although the expression of certain genes (including BGLAP) tended to be increased by the combination of low Mg2+ and high 1,25D concentrations. (bvsalud.org)
  • Expression of the energy substrate transporters in uterine fibroids. (edu.pl)
  • it protects the brain's delicate nerve tissue by preventing many other types of molecules from entering the brain. (medlineplus.gov)
  • The GLUT1 protein also moves glucose between cells in the brain called glia, which protect and maintain nerve cells (neurons). (medlineplus.gov)
  • Having less functional GLUT1 protein reduces the amount of glucose available to brain cells, which affects brain development and function. (medlineplus.gov)
  • Protein kinase C has been implicated in the phosphorylation of the erythrocyte/brain glucose transporter, GLUT1, without a clear understanding of the site(s) of phosphorylation and the possible effects on glucose transport. (elsevierpure.com)
  • This is because the brain is not getting enough glucose, which it needs for energy. (epilepsyu.com)
  • This type of seizure begins in one side of the brain and, like an absence seizure, may or may not involve movements. (epilepsyu.com)
  • Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. (rush.edu)
  • This study reports crystal structures of an α-glycoside-binding protein (αGlyBP, ORF ID: TTHA0356 from Thermus thermophilus HB8) in complex with disaccharide α-glycosides namely trehalose (α-1,1), sucrose (α-1,2), maltose (α-1,4), palatinose (α-1,6) and glucose within a resolution range of 1.6-2.0 Å. (rcsb.org)
  • Acid maltase catalyzes the hydrogenation reaction of maltose to glucose. (medscape.com)
  • In Scotland, the incidence of the disorder has been estimated at 1 in 24,000 newborns. (medlineplus.gov)
  • In a 2-year study of 7 patients with GSD type Ib, Melis et al examined whether the administration of vitamin E could improve or prevent the clinical manifestations of neutropenia and neutrophil dysfunction. (medscape.com)
  • So we now have more agents than ever that we can combine and which don't increase the risk for hypoglycemia, and which can help patients, presumably, with weight loss, helping them reach the targets they have and not just lowering their glucose levels. (medscape.com)
  • There were no significant changes in parathyroid hormone, serum calcium, or urinary calcium excretion in the Phase 1/2 study. (healthcap.eu)
  • Dietary restriction of Mg2+ resulted in reduced serum Mg2+ concentration and urinary Mg2+ excretion, which was similar in the wild-type and knockout groups. (bvsalud.org)
  • Fig. 1: Reciprocal influences between the gut microbiome and key lifestyle and clinical approaches for weight management. (nature.com)
  • Longer-term (24 and 48 h) treatment reduced the expression of lipogenic markers (FA synthase and sterol regulatory element-binding protein-1) and increased the expression of lipolytic [hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL)] and mitochondrial (peroxisome proliferator-activated receptor γ coactivator-1α and carnitine palmitoyltransferase 1) markers. (academic-accelerator.com)
  • The expression of regulatory molecules, TGF-β1/2, phospho-Akt (Ser473), PPARα, sterol regulatory element-binding protein 1 (SREBP-1), fatty acid synthase (FASN), hormone-sensitive lipase (HSL), and acyl dehydrogenases was analyzed in virus-infected hepatocytes. (academic-accelerator.com)
  • Expression of CYP24A1 was higher in all groups receiving 5 nM 1,25D. (bvsalud.org)
  • Expression of genes encoding Mg2+ channels and transporters such as transient receptor potential melastatin 6 (Trpm6), transient receptor potential melastatin 7 (Trpm7), cyclin and CBS domain divalent metal cation transport mediator 2 (Cnnm2), and Slc41a3 were unchanged based on genotype. (bvsalud.org)
  • The small intestine converts dietary fructose into glucose and organic acids. (nature.com)
  • Positron emission tomography-computed tomography showed no metastasis or recurrence of the tumor 1 month before admission. (cdc.gov)
  • cells and disrupts glucose homeostasis. (rush.edu)
  • GSD type Ia and Ib both have the hallmark feature of hypoglycemia, which can lead to life-threatening seizures and prompts the workup early in infancy. (medscape.com)

No images available that match "glucose transporter type 1"